NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Millions of U.S. dollars, except share, per share and metric tons data or unless otherwise noted)
1. The Company
Tronox Holdings plc (referred to herein as "Tronox", the "Company", "we", "us", or "our") operates titanium-bearing mineral sand mines and beneficiation operations in Australia and South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high purity titanium chemicals, including titanium tetrachloride, and Ultrafine© titanium dioxide used in certain specialty applications. Our strategy is to be vertically integrated and produce enough feedstock materials to be as self-sufficient as possible in the production of TiO2 at our nine pigment facilities located in the United States, Australia, Brazil, UK, France, the Netherlands, China and the Kingdom of Saudi Arabia (“KSA”). We believe that vertical integration is the best way to achieve our ultimate goal of delivering low cost, high-quality pigment to our coatings and other TiO2 customers throughout the world. The mining, beneficiation and smelting of titanium bearing mineral sands creates meaningful quantities of zircon, pig iron and the rare-earth bearing mineral, monazite, which we also supply to customers around the world.
We are a public limited company listed on the New York Stock Exchange and are registered under the laws of England and Wales.
Basis of Presentation
We are considered a domestic company in the United Kingdom and, as such, are required to comply with filing requirements in the United Kingdom. Additionally, we are not considered a “foreign private issuer” in the U.S.; therefore, we are required to comply with the reporting and other requirements imposed by the U.S. securities law on U.S. domestic issuers, which, among other things, requires reporting under accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements included in this Form 10-K are prepared in conformity with U.S. GAAP.
Our consolidated financial statements include the accounts of all majority-owned subsidiary companies. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the manner and presentation in the current period.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. It is at least reasonably possible that the effect on the financial statements of a change in estimate due to one or more future confirming events could have a material effect on the financial statements.
2. Significant Accounting Policies
Foreign Currency
The U.S. dollar is our reporting currency for our consolidated financial statements in U.S. GAAP. We determine the functional currency of each subsidiary based on a number of factors, including the predominant currency for revenues, expenditures and borrowings. Adjustments from the remeasurement of non-functional currency monetary assets and liabilities are recorded in “Other income (expense), net” in the Consolidated Statements of Operations. When a subsidiary’s functional currency is not the U.S. dollar, translation adjustments resulting from translating the functional currency financial statements into U.S. dollar equivalents are recorded in “Accumulated other comprehensive loss” in the Consolidated Balance Sheets.
Translation adjustments on intercompany foreign currency receivables and payables that are not expected to be settled in the foreseeable future are reported in the same manner as translation adjustments.
Revenue Recognition
We recognize revenue at a point in time when the customer obtains control of the promised products. For most transactions this occurs when products are shipped from our manufacturing facilities or at a later point when control of the products transfers to the customer at a specified destination or time. All amounts billed to a customer in a sales transaction related to shipping and handling represent revenues earned and are reported as “Net sales” in the Consolidated Statements of Operations. Accruals are made for sales returns, rebates and other allowances, which are recorded in “Net sales” in the Consolidated Statements of Operations and are based on our historical experience and current business conditions. Additionally, we have elected the practical
expedient to exclude sales taxes and similar taxes that we collect from customers on behalf of government authorities from the revenue transaction price. See Note 3.
Cost of Goods Sold
Cost of goods sold includes costs for purchasing, receiving, manufacturing, and distributing products, including raw materials, energy, labor, depreciation, depletion, shipping and handling, freight, warehousing, and other production costs.
Research and Development
Research and development costs, included in “Selling, general and administrative expenses” in the Consolidated Statements of Operations comprised of salaries, building costs, utilities, administrative expenses, third party research, and allocations of corporate costs, were $12 million, $12 million, and $13 million during 2023, 2022, and 2021, respectively, and were expensed as incurred.
Selling, General and Administrative Expenses
Selling, general and administrative expenses include costs related to marketing, research and development, agent commissions, and legal and administrative functions such as corporate management, human resources, information technology, investor relations, accounting, treasury, and tax compliance.
Income Taxes
We use the asset and liability method of accounting for income taxes. The estimation of the amounts of income taxes involves the interpretation of complex tax laws and regulations and how foreign taxes affect domestic taxes, as well as the analysis of the realizability of deferred tax assets, tax audit findings, and uncertain tax positions.
Deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is provided against a deferred tax asset when it is more likely than not that all or some portion of the deferred tax asset will not be realized. We periodically assess the likelihood that we will be able to recover our deferred tax assets and reflect any changes in our estimates in the valuation allowance, with a corresponding adjustment to earnings or other comprehensive income (loss), as appropriate. All available positive and negative evidence is weighed to determine whether a valuation allowance should be recorded.
The amount of income taxes we pay is subject to ongoing audits by federal, state, and foreign tax authorities, which may result in proposed assessments. Our estimate of the potential outcome for any uncertain tax issue is highly judgmental. We assess our income tax positions, and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances, and information available at the reporting date. For those tax positions for which it is more likely than not that a tax benefit will be sustained, we record the amount that has a greater than 50% likelihood of being realized upon settlement with a taxing authority that has full knowledge of all relevant information. Interest and penalties are accrued as part of tax expense, where applicable. If we do not believe that it is more likely than not that a tax benefit will be sustained, no tax benefit is recognized. See Note 5.
Fair Value Measurement
We measure fair value on a recurring basis utilizing valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs, to the extent possible, and consider counterparty credit risk in our assessment of fair value. The fair value hierarchy is as follows:
•Level 1 – Quoted prices in active markets for identical assets and liabilities;
•Level 2 – Quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data; and,
•Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities
See Note 15.
Cash and Cash Equivalents
We consider all investments with original maturities of three months or less to be cash equivalents. We maintain cash and cash equivalents in bank deposit and money market accounts that may exceed federally insured limits. The financial institutions where our cash and cash equivalents are held are generally highly rated and geographically dispersed, and we have a policy to limit the amount of credit exposure with any one institution. We have not experienced any losses in such accounts and believe we are not exposed to significant credit risk.
At both December 31, 2023 and December 31, 2022, we had restricted cash of less than $1 million which was in Australia related to outstanding performance bonds.
Accounts Receivable, net of allowance for credit losses
We perform credit evaluations of our customers, and take actions deemed appropriate to mitigate credit risk. Only in certain specific occasions do we require collateral in the form of bank or parent company guarantees or guarantee payments. We maintain allowances for potential credit losses based on specific customer review and current financial conditions.
Inventories, net
Pigment inventories are stated at the lower of actual cost and net realizable value, net of allowances for obsolete and slow-moving inventory. The cost of inventories is determined using the first-in, first-out method. Carrying values include material costs, labor, and associated indirect manufacturing expenses. Costs for materials and supplies, excluding titanium ore, are determined by average cost to acquire. Feedstock and co-products inventories including titanium ore are stated at the lower of the weighted-average cost of production or market. Inventory costs include those costs directly attributable to products, including all manufacturing overhead but excluding distribution costs. Raw materials are carried at actual cost.
We review the cost of our inventory in comparison to its net realizable value. We also periodically review our inventory for obsolescence. In either case, we record any write-down equal to the difference between the cost of inventory and its estimated net realizable value based on assumptions about alternative uses, market conditions and other factors. Inventories expected to be sold or consumed within twelve months after the balance sheet date are classified as current assets and all other inventories are classified as non-current assets. See Note 8.
Long Lived Assets
Property, plant and equipment, net is stated at cost less accumulated depreciation, and is depreciated over its estimated useful life using the straight-line method as follows: | | | | | |
Land improvements | 10 — 20 years |
Buildings | 10 — 40 years |
Machinery and equipment | 3 — 25 years |
Furniture and fixtures | 10 years |
Maintenance and repairs are expensed as incurred, except for costs of replacements or renewals that improve or extend the lives of existing properties, which are capitalized. Upon retirement or sale, the cost and related accumulated depreciation are removed from the respective account, and any resulting gain or loss is included in “Cost of goods sold” or “Selling, general, and administrative expenses” in the Consolidated Statements of Operations. See Note 9.
We capitalize costs associated with our asset retirement obligations which are generally included in machinery and equipment. See Note 17.
We capitalize interest costs on major projects that require an extended period of time to complete. See Note 13.
Mineral property acquisition costs are capitalized as tangible assets when management determines that probable future benefits consisting of a contribution to future cash inflows have been identified and adequate financial resources are available or are expected to be available as required to meet the terms of property acquisition and anticipated exploration and development expenditures. Mineral leaseholds are depleted over their useful lives as determined under the units of production method. Mineral property exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property through the commencement of production are capitalized. See Note 10.
Intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated useful lives, which generally range from 3 to 20 years. See Note 11.
We evaluate the recoverability of the carrying value of long-lived assets that are held and used whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Under such circumstances, we assess whether the projected undiscounted cash flows of our long-lived assets are sufficient to recover the carrying amount of the asset group being assessed. If the undiscounted projected cash flows are not sufficient, we calculate the impairment amount by discounting the projected cash flows using our weighted-average cost of capital. For assets that satisfy the criteria to be classified as held for sale, an impairment loss, if any, is recognized to the extent the carrying amount exceeds fair value, less cost to sell. The amount of the impairment of long-lived assets is written off against earnings in the period in which the impairment is determined.
Leases
We determine if a contract is or contains a lease at inception of the contract. Our leases are primarily operating leases. Leased assets primarily include office buildings, rail cars and motor vehicles, forklifts, and other machinery and equipment. Our leases primarily have fixed lease payments, with real estate leases typically requiring additional payments for real estate taxes and occupancy-related costs. Certain of our leases also have variable lease payments. Variable lease payments that depend on an index or a rate (such as the Consumer Price Index) are included in our initial measurement of the lease right of use assets and lease liabilities. Variable lease payments that are not index or rate based (such as variable payments based on our performance or use of the leased assets) are recorded as expenses when incurred and excluded from the measurement of right of use assets and lease liabilities. Our leases typically have initial lease terms ranging from 1 to 25 years. Some of our lease agreements include options to renew, extend or early terminate the leases. Lease term is the non-cancellable period of a lease, adjusted by the period covered by an option to extend or terminate the lease if we are reasonably certain to exercise (or not exercise) that option. Our operating leases typically do not contain purchase options we expect to exercise, residual value guarantees or other material covenants.
Operating leases are recorded under “Lease right of use assets”, “Short-term lease liabilities”, and “Long-term lease liabilities” on the Consolidated Balance Sheets. Finance leases are recorded under “Property, plant and equipment net”, “Long-term debt due within one year”, and “Long-term debt” on the Consolidated Balance Sheets. Operating lease right of use ("ROU") assets and lease liabilities are initially recorded at the present value of the future minimum lease payments over the lease term at the commencement date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date in determining the present value of future payments. Lease payments for the initial measurement of lease ROU assets and lease liabilities include fixed payments and variable payments that depend on an index or a rate. Variable lease payments that are not index or rate based are recorded as expenses when incurred. Operating lease ROU assets are amortized on a straight-line basis over the period of the lease. Finance lease assets are amortized on a straight-line basis over the shorter of their estimated useful lives and the lease terms. See Note 16.
Long-term Debt
Long-term debt is stated net of unamortized original issue premium or discount. Premiums or discounts are amortized using the effective interest method with amortization expense recorded in “Interest and debt expense, net” in the Consolidated Statements of Operations. Deferred debt issuance costs related to a recognized debt liability are presented in the Consolidated Balance Sheets as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts and are amortized using the effective interest method with amortization expense recorded in “Interest and debt expense, net” in the Consolidated Statements of Operations. See Note 13.
Asset Retirement Obligations
Asset retirement obligations are recorded at their estimated fair value, and accretion expense is recognized over time as the discounted liability is accreted to its expected settlement value. Fair value is measured using expected future cash outflows discounted at our credit-adjusted risk-free interest rate, which are considered Level 3 inputs. We classify accretion expense related to asset retirement obligations as a production cost, which is included in “Cost of goods sold” in the Consolidated Statements of Operations. See Note 17.
Environmental Remediation and Other Contingencies
We record an undiscounted liability when any of the following occur: 1) a claim or assessment has been asserted, 2) a litigation has commenced, or 3) based on available information, it is probable that a claim or an assessment will be asserted or a litigation will commence; and in addition, the outcome is expected to be unfavorable to us and the associated costs can be reasonably estimated. See Note 18.
Self-Insurance
We are self-insured for certain levels of general and vehicle liability, property, workers’ compensation and health care coverage. The cost of these self-insurance programs is accrued based upon estimated fully developed settlements for known and anticipated claims. Any resulting adjustments to previously recorded reserves are reflected in current operating results. We do not accrue for general or unspecific business risks.
Share-based Compensation
Equity Restricted Share and Restricted Share Unit Awards — The fair value of equity instruments is measured based on the share price on the grant date and is recognized over the vesting period. These awards contain service, market, and/or performance conditions. For awards containing only a service or a market condition, we have elected to recognize compensation costs using the straight-line method over the requisite service period for the entire award. For awards containing a market condition, the fair value of the award is measured using the Monte Carlo simulation under a lattice model approach. For awards containing a performance condition, the fair value is the grant date close price and compensation expense is not recognized until we conclude that it is probable that the performance condition will be met. We reassess the probability at least quarterly. See Note 20.
Defined Benefit Pension and Postretirement Benefit Plans
We recognize the funded status of our defined benefit pension plans and postretirement benefit plans in the Consolidated Balance Sheets. The funded status is measured as the difference between the fair value of plan assets and the benefit obligation at the measurement date. The benefit obligation for the defined benefit plans is the projected benefit obligation (PBO), which represents the actuarial present value of benefits expected to be paid upon retirement based on employee services already rendered and estimated future compensation levels. The benefit obligation for our postretirement benefit plans is the accumulated postretirement benefit obligation (APBO), which represents the actuarial present value of postretirement benefits attributed to employee services already rendered. The fair value of plan assets related to our defined benefit plan represents the current market value of assets held in a trust fund, which is established for the sole benefit of plan participants.
If the fair value of plan assets exceeds the benefit obligation, the plan is overfunded, and the excess is recorded as a prepaid pension asset. On the other hand, if the benefit obligation exceeds the fair value of plan assets, the plan is underfunded, and the deficit is recorded as pension and postretirement healthcare benefits obligation in the Consolidated Balance Sheet. The portion of the pension and postretirement healthcare obligations payable within the next 12 months is recorded in accrued liabilities in the Consolidated Balance Sheet.
Net periodic pension and postretirement benefit cost represents the aggregation of service cost, interest cost, expected return on plan assets, amortization of prior service costs or credits and actuarial gains or losses previously recognized as a component of OCI and it is recorded in the Consolidated Statements of Operations. Net periodic cost is recorded in cost of goods sold and selling, general and administrative expenses in the Consolidated Statements of Operations based on the employees’ respective functions.
Actuarial gains or losses represents the effect of remeasurement on the benefit obligation principally driven by changes in the plan actuarial assumptions. Prior service costs or credits arise from plan amendments. The actuarial gains or losses and prior service costs or credits are initially recognized as a component of Other comprehensive income (loss) in the Consolidated Statement of Comprehensive Income. Those gains or losses and prior service costs or credits are subsequently recognized as a component of net periodic cost.
The measurement of benefit obligations and net periodic cost is based on estimates and assumptions approved by management. These valuations reflect the terms of the plans and use participant-specific information such as compensation, age and years of service, as well as certain assumptions, including estimates of discount rates, expected return on plan assets, rate of compensation increases and mortality rates.
Defined Contribution Plans — We recognize our contribution as expense when they are due. The expense is recorded in cost of goods sold or selling, general and administrative expenses the Consolidated Statements of Operations based on the employees’ respective functions.
Multiemployer Plan — We treat our multiemployer plan like a defined contribution plan. A pension plan to which two or more unrelated employers contribute is generally considered to be a multiemployer plan. As a defined contribution plan, we recognize the contribution for the period as a net benefit cost and any contributions due and unpaid as a liability.
Recently Issued Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, "Improvements to Reportable Segment Disclosures". The amendment requires additional disclosures by public entities, including those with a single reportable segment, to disclose significant segment expenses and other segment items for each reportable segment. The guidance applies to fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating any incremental disclosures required as a result of this standard.
In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures". The amendments in this update apply to all entities that are subject to Topic 740, Income Taxes. The standard requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The amendments in this update are effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. We are currently evaluating any incremental disclosures required as a result of this standard.
Recently Adopted Accounting Pronouncements
In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform Financial Reporting”. This amendment is elective in nature. Amongst other aspects, this standard provides for practical expedients and exceptions to current accounting standards that reference a rate which is expected to be dissolved (e.g., London Interbank Offered Rate “LIBOR”) as it relates to hedge accounting, contract modifications and other transactions that reference this rate, subject to meeting certain criteria. The standard is effective for all entities as of March 12, 2020 through December 31, 2022. In December 2022, the FASB issued ASU 2022-06, which defers the sunset date of ASC 848, Reference Rate Reform, from December 31, 2022 to December 31, 2024. ASU 2022-06 is effective immediately for all entities.
We completed an internal assessment to identify items that were impacted as a result of the dissolution of LIBOR. Based upon this assessment, we determined that this change was most impactful to our intercompany debt agreements and interest rate swap agreements. Upon conversion of these benchmark rates, we elected the practical expedients allowed under this standard which resulted in an immaterial impact to the financial statements. In addition, during the year ended December 31, 2023, we elected to utilize certain exemptions allowed by this pronouncement as it relates to our interest rate swap transactions. Refer to Note 14 for further details.
3. Revenue
Nature of Contracts and Performance Obligations
We primarily generate revenue from selling TiO2 pigment products and related co-products, primarily zircon and pig iron, to our customers. These products are used for the manufacture of paints, coatings, plastics, paper, and a wide range of other applications. We account for a contract with our customer when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable.
Our promise in a contract typically relates to the transferring of a product or multiple distinct products that are substantially the same and that have the same pattern of transfer, representing a single performance obligation within a contract. We have elected to account for shipping and handling activities that occur after control of the products has transferred to the customer as contract fulfillment activities, rather than a separate performance obligation. Amounts billed to a customer in a sales transaction related to shipping and handling activities continue to be reported as “Net sales” and related costs as “Cost of goods sold” in the Consolidated Statements of Operations.
The duration of our contract period is one year or less. As such, we have elected to recognize incremental costs incurred to obtain contracts, which primarily consist of commissions paid to third-party sales agents, as “Selling, general and administrative expenses” in the Consolidated Statements of Operations. Furthermore, we have elected not to disclose the value of unsatisfied performance obligations at each period end, given the original expected duration of our contracts are one year or less.
Transaction Price
Revenue is measured as the amount of consideration that we expect to be entitled in exchange for transferring products to the customer. The transaction price typically consists of fixed cash consideration. We also offer various incentive programs to our customers, such as rebates, discounts, and other price adjustments that represent variable consideration. We estimate variable consideration and include such consideration amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Our estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of our anticipated performance and all information (historical, current and forecasted) that is reasonably available to us. We adjust our estimate of revenue at the earlier of when the amount of consideration we expect to receive changes
or when the consideration becomes fixed. Sales returns rarely happen in our business; therefore, it is unlikely that a significant reversal of revenue will occur.
Sales and similar taxes we collect on behalf of governmental authorities are excluded from the transaction price for the determination of revenue. The expected costs associated with product warranties continue to be recognized as expense when the products are sold. Customer payment terms and conditions vary by contract and customer, although the timing of revenue recognition typically does not differ from the timing of invoicing. Additionally, as we generally do not grant extended payment terms, we have determined that our contracts generally do not include a significant financing component.
Revenue Recognition
We recognize revenue at a point in time when the customer obtains control of the promised products. For most transactions this occurs when products are shipped from our manufacturing facilities or at a later point when control of the products transfers to the customer at a specified destination or time.
Contract Balances
Contract assets represent our rights to consideration in exchange for products that have transferred to a customer when the right is conditional on situations other than the passage of time. For products that we have transferred to our customers, our rights to the consideration are typically unconditional and only the passage of time is required before payments become due. These unconditional rights are recorded as accounts receivable. As of December 31, 2023, and December 31, 2022, we did not have material contract asset balances.
Contract liabilities represent our obligations to transfer products to a customer for which we have received consideration from the customer. When a customer has poor credit worthiness, we may receive advance payment that is accounted for as deferred revenue. Deferred revenue is earned when control of the product transfers to the customer, which is typically within a short period of time from when we received the advanced payment. Contract liability balances as of both December 31, 2023 and December 31, 2022 were less than $1 million. Contract liability balances were reported as “Accrued liabilities” in the Consolidated Balance Sheets. All material contract liabilities as of December 31, 2022 and 2021 were recognized as revenue in “Net sales” in the Consolidated Statements of Operations during the first quarter of 2023 and first quarter of 2022, respectively.
Disaggregation of Revenue
We operate under one operating and reportable segment, Tronox. See Note 23 for details. We disaggregate our revenue from contracts with customers by product type and geographic area. We believe this level of disaggregation appropriately depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors and reflects how our business is managed.
Net sales to external customers by geographic areas where our customers are located were as follows: | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
2023 | | 2022 | | 2021 |
North America | $ | 754 | | | $ | 790 | | | $ | 743 | |
South and Central America | 159 | | | 264 | | | 252 | |
Europe, Middle-East and Africa | 1,131 | | | 1,335 | | | 1,398 | |
Asia Pacific | 806 | | | 1,065 | | | 1,179 | |
Total net sales | $ | 2,850 | | | $ | 3,454 | | | $ | 3,572 | |
Net sales from external customers for each similar type of product were as follows: | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
2023 | | 2022 | | 2021 |
TiO2 | $ | 2,248 | | | $ | 2,693 | | | $ | 2,793 | |
Zircon | 257 | | | 438 | | | 478 | |
Other products | 345 | | | 323 | | | 301 | |
Total net sales | $ | 2,850 | | | $ | 3,454 | | | $ | 3,572 | |
Other products mainly include pig iron, TiCl4 and other mining products. The nature, amount, timing and uncertainty of revenue and cash flows typically do not differ significantly among different products.
4. Other Income (Expense), Net
Other income (expense), net is comprised of the following: | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
Net realized and unrealized foreign currency gains (losses) | $ | 6 | | | $ | (3) | | | $ | 16 | |
Pension and postretirement benefit interest cost, expected return on assets and amortization of actuarial losses | — | | | 4 | | | 5 | |
Pension settlement loss(1) | — | | | (20) | | | — | |
| | | | | |
Breakage fee(2) | — | | | — | | | (18) | |
AMIC technical service support fee (Note 22) | 6 | | | 8 | | | 8 | |
Other, net | (9) | | | (2) | | | 1 | |
Total | $ | 3 | | | $ | (13) | | | $ | 12 | |
_____________________
(1) 2022 amount is a settlement loss related to our U.S. Qualified Plan.
(2) 2021 amount represents the breakage fee associated with the termination of the TTI acquisition.
5. Income Taxes
Our operations are conducted through various subsidiaries in a number of countries throughout the world. We have provided for income taxes based upon the tax laws and rates in the countries in which operations are conducted and income is earned.
Income (loss) before income taxes is comprised of the following:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
United Kingdom | $ | (47) | | | $ | (130) | | | $ | (16) | |
International | 96 | | | 438 | | | 390 | |
Income before income taxes | $ | 49 | | | $ | 308 | | | $ | 374 | |
The income tax (provision) benefit is summarized below: | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
United Kingdom: | | | | | |
Current | $ | 1 | | | $ | — | | | $ | (1) | |
Deferred | — | | | — | | | — | |
International: | | | | | |
Current | (34) | | | (69) | | | (55) | |
Deferred | (330) | | | 261 | | | (15) | |
Income tax (provision) benefit | $ | (363) | | | $ | 192 | | | $ | (71) | |
The following table reconciles the applicable statutory income tax rates to our effective income tax rates for “Income tax (provision) benefit” as reflected in the Consolidated Statements of Operations. | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
Statutory tax rate | 24 | % | | 19 | % | | 19 | % |
Increases (decreases) resulting from: | | | | | |
Tax rate differences | (26) | | | 9 | | | 7 | |
Non-taxable income and expenses | 29 | | | 8 | | | 2 | |
Valuation allowances | 670 | | | (100) | | | (27) | |
Corporate reorganization | — | | | — | | | 17 | |
Tax rate changes | 10 | | | (3) | | | 2 | |
State and local taxes | 14 | | | 1 | | | 1 | |
Prior year accruals | 9 | | | — | | | (2) | |
Branch taxation | — | | | — | | | — | |
Withholding taxes | — | | | 2 | | | 2 | |
Tax credits | — | | | — | | | (2) | |
Expiration of net operating loss | 11 | | | 2 | | | — | |
Other, net | — | | | — | | | — | |
Effective tax rate | 741 | % | | (62) | % | | 19 | % |
Tronox Holdings plc is a U.K. public limited company and the parent company for the business group. The statutory tax rate in the U.K. at December 31, 2023 was 25% and at December 31, 2022 and 2021 was 19%. The statutory rate in the U.K. changed to 25% effective April 1, 2023 and a weighted average rate of 23.5% was applied for the full year 2023.
The effective tax rates in 2023, 2022 and 2021 are all influenced by a variety of factors, primarily income and losses in jurisdictions with valuation allowances, changes in tax rates, non-taxable income and expenses, prior year accruals, and rates different than the United Kingdom statutory rate. The valuation allowances in each year were impacted by items other than income and losses as follows: 2023 was impacted by recording valuation allowances in China and Australia, 2022 was impacted by releasing a valuation allowance in Australia, and 2021 was impacted by releasing a valuation allowance in Saudi Arabia. Additional factors of significance in the above table are as follows: 1) the Non-taxable income and expenses amount for 2022 includes the Venator settlement, 2) the Corporate reorganization amount for 2021 includes the liquidation of the inactive Dutch subsidiary and the write-off of its net operating losses, and 3) the Corporate reorganization amounts for 2021 include the restructuring of our Australian entities. Each of these additional factors were fully offset by valuation allowances.
Net deferred tax assets (liabilities) at December 31, 2023 and 2022 were comprised of the following: | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Deferred tax assets: | | | |
Net operating loss and other carryforwards | $ | 1,800 | | | $ | 1,739 | |
Property, plant and equipment, net | 182 | | | 200 | |
Reserves for environmental remediation and restoration | 53 | | | 47 | |
Obligations for pension and other employee benefits | 50 | | | 46 | |
Investments | 3 | | | 4 | |
Grantor trusts | 609 | | | 621 | |
Inventories, net | 10 | | | 6 | |
Interest | 161 | | | 190 | |
Lease liabilities | 46 | | | 48 | |
Other accrued liabilities | 4 | | | 2 | |
Foreign exchange | 0 | | | 1 | |
Other | 4 | | | 5 | |
Total deferred tax assets | 2,922 | | | 2,909 | |
Valuation allowance associated with deferred tax assets | (1,860) | | | (1,527) | |
Net deferred tax assets | 1,062 | | | 1,382 | |
| | | |
Deferred tax liabilities: | | | |
Inventories, net | (3) | | | (3) | |
Property, plant and equipment, net | (223) | | | (228) | |
Intangible assets, net | (9) | | | (15) | |
Lease assets | (43) | | | (38) | |
Foreign exchange | (6) | | | (4) | |
Interest | (7) | | | (9) | |
Other | (3) | | | (5) | |
Total deferred tax liabilities | (294) | | | (302) | |
Net deferred tax asset | $ | 768 | | | $ | 1,080 | |
| | | |
Balance sheet classifications: | | | |
Deferred tax assets — long-term | $ | 917 | | | $ | 1,233 | |
Deferred tax liabilities — long-term | $ | (149) | | | $ | (153) | |
Net deferred tax asset | $ | 768 | | | $ | 1,080 | |
The net deferred tax assets reflected in the above table include deferred tax assets related to grantor trusts, which were established as Tronox Incorporated emerged from bankruptcy during 2011. The balances relate to the assets contributed to such grantor trusts by Tronox Incorporated and the proceeds from the resolution of previous litigation of $5.2 billion during 2014, which resulted in additional deferred tax assets of $2.0 billion. As the grantor trusts continue to spend funds received from the litigation and earn income from the investment of those funds, the U.S. net operating loss will increase or decrease.
There was an increase to our valuation allowance of $333 million during 2023 and a decrease of $314 million in 2022. The table below sets forth the changes, by jurisdiction: | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
United Kingdom | $ | 11 | | | $ | 13 | |
United States | (18) | | | (5) | |
Australia | 346 | | | (314) | |
| | | |
| | | |
| | | |
Switzerland | (7) | | | (8) | |
China | 1 | | | — | |
| | | |
Total increase (decrease) in valuation allowances | $ | 333 | | | $ | (314) | |
During the year ended December 31, 2023, the Company identified negative evidence concerning our ability to realize the net balance of our Australia group deferred tax assets. This evidence primarily relates to losses generated during the current year and uncertainty regarding the region's ability to generate income in the near term. After weighing all the positive and negative evidence, we determined that it is more likely than not that the Australia deferred tax assets may not be realized. As a result, we recorded a $293 million non-cash charge to tax expense for the year ended December 31, 2023.
The Company has a Swiss entity acquired in the Cristal transaction that had net operating loss carryovers. During the year ended December 31, 2023, a majority of these losses expired unused because the Swiss entity no longer has significant income-generating activities. A valuation allowance was previously carried against these losses and is no longer required.
During the year ended December 31, 2022, the Company had determined that sufficient positive evidence existed to reverse a portion of the valuation allowance in Australia. This reversal resulted in a non-cash deferred tax benefit of $300 million. Our analysis considered all positive and negative evidence, including (i) three years of cumulative income of our Australian subsidiaries, (ii) our continuing and improved profitability over the last twelve months, (iii) estimates of continued profitability based on updated to our latest forecasts, (iv) changes in the factors that drove losses in the past, and (v) an evaluation of specific deferred tax assets for limitations under certain Australian tax provisions. Based on this analysis, we concluded that it is more likely than not that our Australian subsidiaries will be able to utilize all of their deferred tax assets except for those which are classified as Capital Gains Tax (CGT) assets.
At December 31, 2023, we continue to maintain full valuation allowances related to the total net deferred tax assets in the United Kingdom, as we cannot objectively assert that these deferred tax assets are more likely than not to be realized. Future provisions for income taxes in Australia and the United Kingdom will include no tax benefits with respect to losses incurred and tax expense only to the extent of current tax payments until the valuation allowances are eliminated. Additionally, we have valuation allowances against specific tax assets in China, South Africa and the U.S.
These conclusions were reached by the application of ASC 740, Income Taxes, and require that all available positive and negative evidence be weighed to determine whether a valuation allowance should be recorded. The more significant evidential matter in the United Kingdom relates to cumulative book losses. The most significant evidential matter for Australia and South Africa relates to capital losses and assets that cannot be depleted or depreciated for tax purposes.
The deferred tax assets generated by tax loss carryforwards in Australia, China and the United Kingdom have been fully offset by valuation allowances. In the United States, the deferred tax assets generated by tax loss carryforwards are partially offset by a valuation allowance to the extent they are subject to expiration. The expiration of these carryforwards at December 31, 2023 is shown below. The tax loss carryforwards in Australia, Saudi Arabia, France, Brazil and the United Kingdom do not expire. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 2024 | | 2025 | | 2026 | | 2027 | | 2028 | | 2029 - 2040 | | Unlimited | | Total Tax Loss Carryforwards |
United Kingdom | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | (135) | | | $ | (135) | |
Australia | — | | | — | | | — | | | — | | | — | | | — | | | (622) | | | (622) | |
The Netherlands | — | | | — | | | — | | | — | | | — | | | — | | | (122) | | | (122) | |
France | — | | | — | | | — | | | — | | | — | | | — | | | (179) | | | (179) | |
Saudi Arabia | — | | | — | | | — | | | — | | | — | | | — | | | (4) | | | (4) | |
| | | | | | | | | | | | | | | |
China | — | | | — | | | — | | | (3) | | | (6) | | | — | | | — | | | (9) | |
Brazil | — | | | — | | | — | | | — | | | — | | | — | | | (11) | | | (11) | |
Other | — | | | — | | | — | | | — | | | — | | | — | | | (2) | | | (2) | |
U.S. Federal | — | | | — | | | — | | | — | | | — | | | (3,919) | | | (334) | | | (4,253) | |
U.S. State | (12) | | | (39) | | | (66) | | | (27) | | | (12) | | | (3,969) | | | (19) | | | (4,144) | |
Total tax loss carryforwards | $ | (12) | | | $ | (39) | | | $ | (66) | | | $ | (30) | | | $ | (18) | | | $ | (7,888) | | | $ | (1,428) | | | $ | (9,481) | |
At December 31, 2023, Tronox Holdings plc had foreign subsidiaries with undistributed earnings. Although we would not be subject to income tax on these earnings, amounts totaling $535 million are in specific jurisdictions which we assert are indefinitely reinvested outside of the parents' taxing jurisdictions. These amounts could be subject to withholding tax if distributed, but the Company has made no provision for tax related to these undistributed earnings. The Company has removed its assertion that earnings in China are indefinitely reinvested, and the withholding tax accruals for potential repatriations from that jurisdiction are now reflected in the effective tax rate reconciliation above.
The noncurrent liabilities section of our Consolidated Balance Sheet does not reflect any reserves for uncertain tax positions for either 2023 or 2022.
Our France returns are closed through 2020. Our Brazil, China, Netherlands, South Africa, U.K. and U.S. returns are closed through 2019. Our Australia returns are being held open back to 2017 for an on-going risk review.
We believe that we have made adequate provision for income taxes that may be payable with respect to years open for examination; however, the ultimate outcome is not presently known and, accordingly, additional provisions may be necessary and/or reclassifications of noncurrent tax liabilities to current may occur in the future.
During the year ended December 31, 2023, the United Kingdom enacted legislation consistent with guidance from the Organization for Economic Co-operation and Development ("OECD") for the implementation of Pillar Two, effective in 2024. The Company does not believe this will have a significant impact on future financial results.
6. (Loss) Income Per Share
The computation of basic and diluted (loss) income per share for the periods indicated is as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
Numerator – Basic and Diluted: | | | | | |
Net (loss) income | $ | (314) | | | $ | 500 | | | $ | 303 | |
Less: Net income attributable to noncontrolling interest | 2 | | | 3 | | | 17 | |
Net (loss) income available to ordinary shares | $ | (316) | | | $ | 497 | | | $ | 286 | |
| | | | | |
Denominator – Basic and Diluted: | | | | | |
Weighted-average ordinary shares, basic (in thousands) | 156,397 | | | 154,867 | | | 152,056 | |
Weighted-average ordinary shares, diluted (in thousands) | 156,397 | | | 157,110 | | | 157,945 | |
| | | | | |
Net (loss) income per Ordinary Share: | | | | | |
Basic net (loss) income per ordinary share | $ | (2.02) | | | $ | 3.21 | | | $ | 1.88 | |
Diluted net (loss) income per ordinary share | $ | (2.02) | | | $ | 3.16 | | | $ | 1.81 | |
Net (loss) income per ordinary share amounts were calculated from exact, unrounded net (loss) income and share information. Anti-dilutive shares not recognized in the diluted net (loss) income per share calculation for the years ended December 31, 2023, 2022 and 2021 were as follows: | | | | | | | | | | | | | | | | | |
| Shares |
| 2023 | | 2022 | | 2021 |
Options | 217,643 | | | 515,092 | | | 414,296 | |
Restricted share units | 2,475,125 | | | 1,590,086 | | | — | |
7. Accounts Receivable Securitization Program
On March 15, 2022, the Company entered into an accounts receivable securitization program (“Securitization Facility”) with a financial institution ("Purchaser"), through our wholly-owned special purpose bankruptcy-remote subsidiary Tronox Securitization LLC (“ SPE”). The purpose of this program is to enhance the Company's financial flexibility by providing
additional liquidity. The Securitization Facility permitted the SPE to sell accounts receivable up to $75 million (the “Facility
Limit”). Under the Securitization Facility, our wholly-owned U.S. operating subsidiary, Tronox LLC (“Originator”), sells its
entire accounts receivable on a periodic basis to the SPE. The SPE in turn sells undivided interests in the receivables that meet
certain eligibility criteria, pursuant to the terms of a receivable purchase agreement, to the Purchaser in exchange for cash, not to
exceed the Facility Limit. The SPE retains the remaining receivables as unsold receivables which are pledged as a collateral for
the sold receivables to which the purchaser is granted a first priority security interest.
Following the sale of the receivables by the Originator to the SPE, the receivables are legally isolated from Tronox and its affiliated entities, and upon the subsequent sale and transfer of the receivables from the SPE to the administrative agent, effective control of the receivables is passed to the purchaser, which has all rights, including the right to pledge or sell the receivables. Any new receivables that are not sold to the purchaser by the SPE are added to the unsold receivables held as collateral.
In November 2022, the Securitization Facility was amended (the "First Amendment") to include receivables generated by our wholly-owned Australian operating subsidiaries, Tronox Pigment Pty Ltd., Tronox Pigment Bunbury Ltd. and Tronox Mining Australia Ltd. which increased the Facility Limit to $200 million and extended the program term to November 2025. Following
this amendment, we sold additional accounts receivable in exchange for net cash proceeds of $72 million, for a total aggregate amount of $147 million for the combined program.
In June 2023, the Company entered into an additional amendment (the “Second Amendment”) to further include receivables generated by our wholly-owned European operating subsidiaries Tronox Pigment Holland BV and Tronox Pigment UK Limited. Neither the facility limit nor the program term were changed as a result of the Second Amendment, which remain at $200 million and November 2025, respectively. As a result of the Second Amendment, during the year ended December 31, 2023, we incurred $1 million of transaction costs, which are recorded in "Other income (expense), net" in our Consolidated Statement of Operations.
As the Company does not maintain effective control over the sold receivables, we derecognize the sold receivables from our
Consolidated Balance Sheet and classify the cash proceeds as source of cash from operating activities in our Consolidated Statement of Cash Flows.
The program is structured on a revolving basis under which cash collections from receivables are used to fund additional
purchases of receivables at 100% face value, not to exceed the facility limit. At December 31, 2023 and 2022, the total value of accounts receivable sold under the Securitization Facility and derecognized from the Company's Consolidated Balance Sheet was $186 million and $123 million, respectively. This resulted in the Company recording $5 million and $24 million within "Accounts payable" on the Consolidated Balance Sheet at December 31, 2023 and 2022, respectively, as this amount is due to the Purchaser as a result of a periodic decrease in accounts receivable sold to the Purchaser, which was paid in January 2024 and January 2023, respectively. Additionally, at December 31, 2023 and 2022, respectively, we retained $129 million and $69 million of unsold receivables that we pledged as collateral for the sold receivables.
The following table sets forth a summary of the receivables sold and fees incurred under the program during the related periods:
| | | | | | | | |
| Year Ended December 31, |
| 2023 | 2022 |
Cash proceeds from collections reinvested in the program | $ | 821 | | $ | 426 | |
Incremental accounts receivables sold | 884 | | 549 | |
Fees incurred1 | 11 | | 2 | |
1 Fees due to the Purchaser relate to monthly utilization of the Securitization Facility and are recorded in "Other income (expense), net" in our Consolidated Statements of Operations.
8. Inventories, net
Inventories, net consisted of the following: | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Raw materials | $ | 352 | | | $ | 261 | |
Work-in-process | 141 | | | 125 | |
Finished goods, net | 688 | | | 641 | |
Materials and supplies, net | 240 | | | 251 | |
Inventories, net | $ | 1,421 | | | $ | 1,278 | |
Materials and supplies, net consists of processing chemicals, maintenance supplies, and spare parts, which will be consumed directly and indirectly in the production of our products.
At December 31, 2023, there was approximately $57 million of inventory that is not expected to be sold within in one year and as such, has been recorded in "Other long-term assets" on the Consolidated Balance Sheet.
At December 31, 2023 and 2022, inventory obsolescence reserves were $42 million and $42 million, respectively. At December 31, 2023 and December 31, 2022, reserves for lower of cost and net realizable value were $50 million and $27 million, respectively.
9. Property, Plant and Equipment
Property, plant and equipment, net of accumulated depreciation, consisted of the following: | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Land and land improvements | $ | 237 | | | $ | 226 | |
Buildings | 404 | | | 390 | |
Machinery and equipment | 2,530 | | | 2,330 | |
Construction-in-progress | 319 | | | 370 | |
Other | 60 | | | 62 | |
Subtotal | 3,550 | | | 3,378 | |
Less: accumulated depreciation | (1,715) | | | (1,548) | |
Property, plant and equipment, net | $ | 1,835 | | | $ | 1,830 | |
Substantially all the Property, plant and equipment, net is pledged as collateral for our debt. See Note 13.
The table below summarizes depreciation expense related to property, plant and equipment for the periods presented, recorded in the specific line items in our Consolidated Statements of Operations: | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
Cost of goods sold | $ | 210 | | | $ | 205 | | | $ | 222 | |
Selling, general and administrative expenses | 4 | | | 4 | | | 5 | |
Total | $ | 214 | | | $ | 209 | | | $ | 227 | |
10. Mineral Leaseholds, net
Mineral leaseholds, net of accumulated depletion, consisted of the following: | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Mineral leaseholds | $ | 1,260 | | | $ | 1,282 | |
Less accumulated depletion | (606) | | | (581) | |
Mineral leaseholds, net | $ | 654 | | | $ | 701 | |
Depletion expense related to mineral leaseholds during 2023, 2022, and 2021 was $30 million, $29 million, and $37 million, respectively, and was recorded in “Cost of goods sold” in the Consolidated Statements of Operations.
11. Intangible Assets, net
Intangible Assets, net of accumulated amortization, consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 |
| Gross Cost | | Accumulated Amortization | | Net Carrying Amount | | Gross Cost | | Accumulated Amortization | | Net Carrying Amount |
Customer relationships | $ | 291 | | | $ | (250) | | | $ | 41 | | | $ | 291 | | | $ | (231) | | | $ | 60 | |
TiO2 technology | 93 | | | (44) | | | 49 | | | 93 | | | (37) | | | 56 | |
Internal-use software and other | 201 | | | (48) | | | 153 | | | 179 | | | (45) | | | 134 | |
Intangible assets, net | $ | 585 | | | $ | (342) | | | $ | 243 | | | $ | 563 | | | $ | (313) | | | $ | 250 | |
As of December 31, 2023 and 2022, internal-use software included approximately $125 million and $106 million, respectively, of capitalized software costs which are not being amortized as the software is not ready for its intended use.
The table below summarizes amortization expense related to intangible assets for the periods presented, recorded in the specific line items in our Consolidated Statements of Operations: | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
Cost of goods sold | $ | 3 | | | $ | 2 | | | $ | 2 | |
Selling, general and administrative expenses | 28 | | | 29 | | | 31 | |
Total | $ | 31 | | | $ | 31 | | | $ | 33 | |
Estimated future amortization expense related to intangible assets is $32 million for 2024, $39 million for 2025, $26 million for 2026, $24 million for 2027, $24 million for 2028 and $98 million thereafter.
12. Balance Sheet and Cash Flows Supplemental Information
Accrued liabilities consisted of the following: | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Employee-related costs and benefits | $ | 111 | | | $ | 107 | |
Related party payables | 1 | | | 15 | |
Interest | 16 | | | 15 | |
Sales rebates | 36 | | | 37 | |
Taxes other than income taxes | 6 | | | 13 | |
Asset retirement obligations | 14 | | | 8 | |
| | | |
Other accrued liabilities | 46 | | | 57 | |
Accrued liabilities | $ | 230 | | | $ | 252 | |
Additional supplemental cash flow information for the year ended and as of December 31, 2023, 2022 and 2021 is as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
Supplemental non cash information: | 2023 | | 2022 | | 2021 |
Operating activities - Chloride slag inventory purchases made from AMIC | $ | 51 | | | $ | — | | | $ | — | |
Operating activities - reduction of Hawkins Point environmental obligation | $ | — | | | $ | 12 | | | $ | — | |
Operating activities - MGT sales made to AMIC | $ | 6 | | | $ | 3 | | | $ | 4 | |
Operating activities - Interest expense on MGT loan | $ | 2 | | | $ | 1 | | | $ | 1 | |
Investing activities - In-kind receipt of AMIC loan repayment | $ | 51 | | | $ | — | | | $ | — | |
Investing activities - sale of Hawkins Point land | $ | — | | | $ | 12 | | | $ | — | |
| | | | | |
| | | | | |
Financing activities - Acquisition of noncontrolling interest | $ | — | | | $ | — | | | $ | 125 | |
Financing activities - Repayment of MGT loan | $ | 6 | | | $ | 3 | | | $ | 3 | |
Financing activities - Initial commercial insurance premium financing agreement | $ | 18 | | | $ | 21 | | | $ | — | |
| | | | | |
| December 31, |
| 2023 | | 2022 | | 2021 |
Capital expenditures acquired but not yet paid | $ | 67 | | | $ | 72 | | | $ | 75 | |
13. Debt
Long-term Debt
Long-term debt, net of an unamortized discount and debt issuance costs, consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Original Principal | | Annual Interest Rate | | Maturity Date | | December 31, 2023 | | December 31, 2022 |
Term Loan Facility, net of unamortized discount(1) | $ | 1,300 | | | Variable | | 3/11/2028 | | $ | 898 | | | $ | 898 | |
2022 Term Loan Facility, net of unamortized discount(1) | 400 | | | Variable | | 4/4/2029 | | 390 | | | 393 | |
2023 Term Loan Facility, net of unamortized discount(1) | 350 | | | Variable | | 8/16/2028 | | 347 | | | — | |
Senior Notes due 2029 | 1,075 | | | 4.63 | % | | 3/15/2029 | | 1,075 | | | 1,075 | |
Standard Bank Term Loan Facility(1) | 98 | | | Variable | | 11/11/2026 | | 64 | | | 77 | |
Australian Government Loan, net of unamortized discount | N/A | | N/A | | 12/31/2036 | | 1 | | | 1 | |
MGT Loan(2) | 36 | | | Variable | | Variable | | 25 | | | 30 | |
Finance leases | | | | | | | 43 | | | 47 | |
Long-term debt | | | | | | | 2,843 | | | 2,521 | |
Less: Long-term debt due within one year | | | | | | | (27) | | | (24) | |
Debt issuance costs | | | | | | | (30) | | | (33) | |
Long-term debt, net | | | | | | | $ | 2,786 | | | $ | 2,464 | |
(1)The average effective interest rate, including impacts of our interest rate swap, for the Term Loan Facility was 6.6% and 4.8% for the year ended December 31, 2023 and 2022, respectively. The average effective interest rate on the 2022 Term Loan Facility was 8.7% and 5.8% for the year ended December 31, 2023 and 2022, respectively. The average effective interest rate on the 2023 Term Loan Facility was 10.1% for the year ended December 31, 2023. The average effective interest rate on the Standard Bank Term Loan Facility was 10.3% and 7.2% for the year ended December 31, 2023 and 2022, respectively.
(2)The MGT loan is a related party debt facility. Average effective interest rate on the MGT loan was 6.0% and 4.4% during the year ended December 31, 2023 and 2022, respectively. Refer below for further details.
At December 31, 2023, the scheduled maturities of our long-term debt were as follows: | | | | | |
| Total Borrowings |
2024 | 27 | |
2025 | 28 | |
2026 | 67 | |
2027 | 16 | |
2028 | 1,247 | |
Thereafter | 1,468 | |
Total | 2,853 | |
Remaining accretion associated with the Term Loan Facility, the 2022 Term Loan Facility and the 2023 Term Loan Facility | (10) | |
Total borrowings | 2,843 | |
Long-term Debt
Term Loan Facility and Cash Flow Revolver
On March 11, 2021, Tronox Finance LLC (the "Borrower", the Borrower's indirect parent company, Tronox Holdings plc (the "Company"), and certain of the Company's subsidiaries, entered into an amendment and restatement of its then existing senior secured first lien term loan credit facility dated as of September 22, 2017 pursuant to which, among other things, the Borrower amended and restated such existing credit facility with a new amended and restated senior secured first lien credit agreement dated as of September 22, 2017 (as amended through and including March 11, 2021, the "New Credit Agreement") with a syndicate of lenders and HSBC Bank USA, National Association, as administrative agent and collateral agent. The New Credit Agreement provides the Borrower with (a) a new seven-year term loan facility (the "Term Loan Facility") in an aggregate
initial principal amount of $1.3 billion and (b) new five-year cash flow revolving facility (the "Cash Flow Revolver") providing initial revolving commitments of $350 million and a sublimit of $125 million for letters of credit. The maturity date on the Term Loan Facility and the Cash Flow Revolver is March 11, 2028 and March 11, 2026, respectively.
Subject to certain customary and other exceptions, the obligations of the Borrower under the New Credit Agreement are (a) guaranteed on a joint and several basis by the Company and certain of the Company's restricted subsidiaries, and (b) secured by a first priority lien on substantially all of the Borrower's and gurantors' assets, including inventory, receivables and related assets, and equipment, equity interests in subsidiaries, and material real property, in each case subject to certain limitations and principles.
In connection with entering into the New Credit Agreement, the Company terminated all remaining commitments and repaid all obligations under its prior term loan facility and prior revolving credit facility totaling $1.6 billion (of which $313 million of the principal under the prior term loan facility was repaid with cash on hand). As a result of this transaction in accordance with ASC 470, we recognized approximately $4 million in "Loss on Extinguishment of Debt" recorded in the Consolidated Statements of Operations for the year ended December 31, 2021. Additionally, during the year ended December 31, 2021, the Company made several voluntary prepayments totaling $398 million on the Term Loan Facility. As a result, we recognized approximately $9 million in "Loss on Extinguishment of Debt" recorded in the Consolidated Statements of Operations for the year ended December 31, 2021.
In June 2023, in anticipation of Reference Rate Reform, we amended our interest rate terms of the Term Loan Facility and Cash Flow Revolver from LIBOR to SOFR pursuant to the New Credit Agreement (the "Second Amendment"). The Term Loan Facility and Cash Flow Revolver bear interest at either the base rate or the SOFR rate, at the Company's discretion, in each case plus an applicable margin. Based on our first lien net leverage ratio pursuant to the credit agreement, the applicable margin under the Term Loan Facility and Cash Flow Revolver as of December 31, 2023 was 2.50% and 2.25%, respectively.
Commencing June 30, 2021, the Cash Flow Revolver contains a springing financial covenant when a loan amount is drawn exceeding 35% of the Cash Flow Revolver. In this instance, the first lien net leverage ratio shall not exceed 4.75x at quarter end testing period.
During the year ended December 31, 2022, we drew down $133 million on our Cash Flow Revolver and repaid $103 million as of December 31, 2022. As of December 31, 2022, there was $30 million outstanding revolving credit loans (recorded within "Short-term debt" on the Consolidated Balance Sheet) under the Cash Flow Revolver, which was fully repaid during the year ended December 31, 2023. The average effective interest rate on the Cash Flow Revolver for the year ended December 31, 2022 was 5.1%. Additionally, there was $7 million of issued and undrawn letters of credit under the Cash Flow Revolver as of December 31, 2023. Additionally, in connection with the sale of the Hawkins Point Plant (refer to Note 18 - Commitments & Contingencies for further details), in December 2022, a $50 million undrawn letter of credit was issued as a bi-lateral, stand-alone arrangement. Debt issuance costs associated with the Cash Flow Revolver of $1 million and $2 million were included in “Other long-term assets” in the Consolidated Balance Sheets at December 31, 2023 and 2022, respectively, and are being amortized over the life of the Cash Flow Revolver.
2022 Term Loan Facility
On April 4, 2022, the Borrower, the Company, certain of the Company's subsidiaries, the incremental term lender party thereto, and HSBC Bank USA. National Association, as Administrative Agent and Collateral Agent, entered into Amendment No. 1 to the New Credit Agreement (the "First Amendment"). The First Amendment provides the Borrower with a new seven-year incremental term loan facility (the "2022 Term Loan Facility" and, the loans thereunder, the "2022 Incremental Term Loans") under the New Credit Agreement in an aggregate initial principal amount of $400 million.
The obligations of the Borrower under the 2022 Term Loan Facility are guaranteed and secured by the same guarantees and liens under the New Credit Agreement with respect to the Term Loan Facility (as discussed above). The 2022 Incremental Term Loans are a separate class of loans under the credit agreement, and if the Borrower elects to make an optional prepayment under the credit agreement or is required to make a mandatory prepayment under the credit agreement, the Borrower, may, in each case, select which class or classes of loans to prepay.
The 2022 Incremental Term Loans will amortize in equal quarterly installments in an aggregate annual amount equal to 1.0% of the original principal amount of the 2022 Incremental Term Loans commencing with the second full fiscal quarter after the effective date of the 2022 Incremental Term Loan Facility. The final maturity of the 2022 Incremental Term Loans will occur on the seventh anniversary of the effective date of the 2022 Incremental Term Loan Facility. The 2022 Incremental Term Loan Facility permits amendments thereto whereby individual lenders may extend the maturity date of their outstanding loans upon the Borrower's request without the consent of any other lender, so long as certain conditions are met.
The 2022 Incremental Term Loans shall bear interest, at the Borrower's option, at either the base or the SOFR rate, in each case plus an applicable margin. The applicable margin in respect of the 2022 Incremental Loans is 2.25% per annum, for base rate
loans, or 3.25% per annum, for SOFR rate loans. The 2022 Incremental Term Loans have an interest rate floor of 0.50%. As of December 31, 2023, the applicable margin under the 2022 Term Loan Facility was 3.25%.
The 2022 Incremental Term Loan Facility contains the same negative covenants applicable to the term loans outstanding under the New Credit Agreement immediately prior to the effectiveness of the First Amendment, which covenants, subject to certain limitations, thresholds and exceptions, limit the Company and its restricted subsidiaries to (among other restrictions): incur indebtedness; grant liens; pay dividends and make subsidiary and certain other distributions; sell assets; make investments; enter into transactions with affiliates; and make certain modifications to material documents (including organizational documents).
The proceeds of the 2022 Incremental Term Loans were used on April 4, 2022, along with cash on hand, to redeem previous senior notes of $500 million. As a result of this transaction, we recognized approximately $21 million, including a call premium of $18 million, in "Loss on extinguishment of debt" on the Consolidated Statements of Operations for the year ended December 31, 2022.
As of December 31, 2023, the total outstanding principal balance is $393 million, of which $4 million is recorded within "Long-term debt due within one year" on the Consolidated Balance Sheet.
2023 Term Loan Facility
In August 2023, the Borrower, the Company, certain of the Company’s subsidiaries, the incremental term lender party thereto and HSBC Bank USA, National Association, as Administrative Agent and Collateral Agent, entered into Amendment No. 3 to the New Credit Agreement (the "Third Amendment"). The Third Amendment provides the Borrower with a new five-year incremental term loan facility ("the 2023 Term Loan Facility" and, the loans thereunder, the "2023 Incremental Term Loans") under the New Credit Agreement in an aggregate initial principal amount of $350 million. A portion of the proceeds of the 2023 Term Loan Facility were used to repay $159 million of then-outstanding borrowings under the Company's existing revolving credit facilities and to enhance available liquidity for upcoming capital expenditures.
The obligations of the Borrower under the 2023 Term Loan Facility are guaranteed and secured by the same guarantees and liens under the New Credit Agreement with respect to the Term Loan Facility and 2022 Term Loan Facility (as discussed above). The 2023 Incremental Term Loans are a separate class of loans under the credit agreement, and if the Borrower elects to make an optional prepayment under the credit agreement or is required to make a mandatory prepayment under the credit agreement, the Borrower, may, in each case, select which class or classes of loans to prepay.
The 2023 Incremental Term Loans will amortize in equal quarterly installments in an aggregate annual amount equal to 1.0% of the original principal amount of the 2023 Incremental Term Loans commencing with the second full fiscal quarter after the effective date of the 2023 Incremental Term Loan Facility. The final maturity of the 2023 Incremental Term Loans will occur on August 16, 2028. The 2023 Incremental Term Loan Facility permits amendments thereto whereby individual lenders may extend the maturity date of their outstanding loans upon the Borrower’s request without the consent of any other lender, so long as certain conditions are met.
The 2023 Incremental Term Loans bear interest, at the Borrower's option, at either the base or the SOFR rate, in each case plus an applicable margin. The applicable margin in respect of the 2023 Incremental Term Loans is 2.50% per annum for base rate loans, or 3.50% per annum for SOFR rate loans. The 2023 Incremental Term Loans have an interest rate floor of 0.50%. As of December 31, 2023, the applicable margin under the 2023 Term Loan Facility was 3.50%.
The 2023 Incremental Term Loan Facility contains the same negative covenants applicable to the term loans outstanding under the New Credit Agreement immediately prior to the effectiveness of the Third Amendment, which covenants, subject to certain limitations, thresholds and exceptions, limit the Company and its restricted subsidiaries to (among other restrictions): incur indebtedness; grant liens; pay dividends and make subsidiary and certain other distributions; sell assets; make investments; enter into transactions with affiliates; and make certain modifications to material documents (including organizational documents).
As of December 31, 2023, the total outstanding principal balance is $350 million, of which $4 million is recorded within "Long-term debt due within one year" on the Consolidated Balance Sheet.
Senior Notes due 2029
On March 15, 2021, Tronox Incorporated closed an offering of $1,075 million aggregate principal amount of its 4.625% senior notes due 2029 (the "Senior Notes due 2029"). The notes were offered at par and issued under an indenture dated as of March 15, 2021 among the Company and certain of the Company's restricted subsidiaries as guarantors and Wilmington Trust, National Association. The Senior Notes due 2029 provide, among other thing, that the Senior Notes due 2029 are guaranteed by the Company and certain of the Company's restricted subsidiaries, subject to certain exceptions. The Senior Notes due 2029 and related guarantees are the senior obligations of the Company and the guarantors. The Senior Notes due 2029 have not been
registered under the Securities Act, or any state securities laws, and may not be offered or sold in the United States absent registration requirements. The terms of the indenture, among other things, limit, in certain circumstances, the ability of the Company and its restricted subsidiaries to: incur secured indebtedness, incur indebtedness at a non-guarantor subsidiary, engage in certain sale-leaseback transactions and merge, consolidate or sell substantially all of their assets.
During the year ended December 31, 2021, the Company utilized the proceeds of the Senior Notes due 2029 to repay our previous senior notes which had an aggregate outstanding principal balance of $1.1 billion. As a result of this transaction, we recorded $52 million of debt extinguishment costs, including call premiums of $40 million in the aggregate on the previous senior notes, in "Loss on Extinguishment of Debt" on the Consolidated Statement of Operations for the year ended December 31, 2021.
Standard Bank Term Loan Facility and Revolving Credit Facility
During the year ended December 31, 2021, we made several voluntary prepayments totaling R1,040 million (approximately $69 million) on our previous facility with Standard Bank as well as mandatory quarterly repayments totaling approximately $24 million. No prepayment penalties were required as a result of this principal prepayment. Additionally, during the year ended December 31, 2021, we repaid the remaining outstanding balance of R390 million (approximately $26 million) of the previous facility with Standard Bank and entered into an amendment and restatement with Standard Bank as is discussed below.
On October 1, 2021, Tronox Minerals Sands Proprietary Limited, a wholly-owned subsidiary of the Company, entered into an amendment and restatement of a new credit facility with Standard Bank. The new credit facility provides the Company with (a) a new five-year term loan facility in an aggregate principal amount of R1.5 billion (approximately $98 million) (the "Standard Bank Term Loan Facility") and (b) a new three-year revolving credit facility (the "Standard Bank Revolving Credit Facility") providing initial revolving commitments of R1.0 billion (approximately $55 million at the December 31, 2023 exchange rate). The maturity date on the Standard Bank Term Loan Facility and the Standard Bank Revolving Credit Facility is November 11, 2026 and October 1, 2024, respectively. The Standard Bank Term Loan Facility has a delayed draw feature up to thirty business days from the effective date of the executed credit agreement. Mandatory capital repayments of R37.5 million (approximately $2 million at the December 31, 2023 exchange rate) are scheduled quarterly with the first mandatory repayment which started in December 2021.
Both the Standard Bank Term Loan Facility and the Standard Bank Revolving Credit Facility shall bear interest at an adjusted JIBAR rate plus an applicable margin. The applicable margin on the Standard Bank Term Loan Facility is 2.35%. The applicable margin on the Standard Bank Revolving Credit Facility is based upon average credit utilization during any interest period. If the revolving credit facility utilization is less than 33%, less than 66% but greater than 33%, or greater than 66%, the applicable margin is 2.10%, 2.25%, and 2.40%, respectively.
Pursuant to the credit agreement, on November 11, 2021, the Company drew down the total outstanding principal balance of R1.5 billion (approximately $98 million) on the Standard Bank Term Loan Facility. As of December 31, 2023, the total outstanding principal balance is R1.2 billion (approximately $64 million at the December 31, 2023 exchange rate), of which R150 million (approximately $8 million at the December 31, 2023 exchange rate) is recorded within "Long-term debt due within one year" on the Consolidated Balance Sheet. Additionally, during the year ended December 31, 2023, we drew down R650 million (approximately $36 million at the December 31, 2023 exchange rate) under the Standard Bank Revolving Credit Facility for general corporate purposes and fully repaid the outstanding amount during the year.
Australian Government Loan
We maintain an interest-free loan with the Australian government (“Australian Government Loan”) that is subject to renewal every 5 years and is contingent on renewal of our Australind site leases with final maturity in December 2036. The loan balance due upon maturity is AUD 6 million (approximately $4 million at the December 31, 2023 exchange rate). At December 31, 2023, the discounted value on the Australian Government Loan was approximately AUD 2 million (approximately $1 million at the December 31, 2023 exchange rate).
MGT Loan
On December 17, 2020, we completed our agreement with Cristal to acquire certain assets co-located at our Yanbu facility which produce metal grade TiCl4 (“MGT”) in exchange for a $36 million note payable. Repayment of the note payable is based on a fixed U.S. dollar per metric ton quantity of MGT delivered by us to Advanced Metal Industries Cluster and Toho Titanium Metal Co. Ltd (ATTM) over time and therefore the ultimate maturity date is variable in nature. If ATTM fails to purchase MGT from us under certain contractually agreed upon conditions, then at our election we may terminate the MGT supply agreement with ATTM and will no longer owe any amount under the loan agreement with Cristal. We currently estimate the ultimate maturity to be between approximately five to six years, subject to actual future MGT production levels. The interest rate is based
on the Saudi Arabian Interbank Offered Rate (“SAIBOR”) plus a premium. As of December 31, 2023, the outstanding balance of the note payable was $25 million, of which $7 million is expected to be paid within the next twelve months (recorded within "Long-term debt due within one year" on our Consolidated Balance Sheet). Refer to Note 22 for further information on the MGT transaction.
Tikon Loan
We maintained a working capital debt agreement in China (“Tikon Loan”) that matured in May of 2021. The Tikon Loan bore interest based on an official lending basis rate per annum as announced and published by the People’s Bank of China plus a 7% premium. During the year ended December 31, 2021, we repaid the remaining outstanding principal balance of CNY 111 million (approximately $17 million). No prepayment penalties were required as a result of these principal prepayments.
Short-term Debt
Cash Flow Revolver
For a description of the Cash Flow Revolver, see details above under "Term Loan Facility and Cash Flow Revolver".
Standard Bank Revolving Credit Facility
For a description of the Standard Bank Revolving Credit Facility, see details above under "Standard Bank Term Loan Facility and Revolving Credit Facility".
Emirates Revolver
In June 2023, Tronox Pigment UK Limited, as borrower, and Tronox Holdings plc, as guarantor, entered into a new revolving credit facility with Emirates NBD PJSC (“Emirates”) which replaced the existing revolving credit facility with Emirates. The new Emirates revolving credit facility is secured by inventory of Tronox Pigment UK Limited and will mature in June 2024. The facility limit is 50 million Pound Sterling (approximately $64 million at the December 31, 2023 exchange rate) and can be drawn in either Pound Sterling, Euro or US Dollar. Under the terms of the revolver, for U.S. dollar borrowings, the interest rate is SOFR plus 1.75%, for Euro borrowings, the interest rate is Euribor plus 1.75% and for Pound Sterling borrowings, the interest rate is SONIA plus 1.75%. During the year ended December 31, 2023, we drew down 35 million Pound Sterling (approximately $43 million) and fully repaid the outstanding amount as of December 31, 2023.
SABB Credit Facility
On October 16, 2019, our KSA subsidiary entered into a short-term working capital facility with the Saudi British Bank (“SABB Facility”) for an amount up to SAR 70 million (approximately $19 million). The SABB Facility bears interest at the Saudi Inter Bank Offered Rate plus 180 basis points on outstanding balances. In November 2023, the Company amended the agreement which amongst other things, extended the maturity date of the SABB Credit Facility from November 30, 2023 to November 30, 2024 and increased the facility limit to SAR 75 million (approximately $20 million at the December 31, 2023 exchange rate). During the year ended December 31, 2023, we drew down SAR 16 million (approximately $4 million at the December 31, 2023 exchange rate) under the SABB Facility for general corporate purposes and fully repaid the outstanding amount as of December 31, 2023.
Itaù Unibanco S.A. Credit Facility
In November 2022, our Brazilian subsidiary entered into a working capital facility with Itaù Unibanco S.A. in Brazil for an amount up to 30 million BRL (approximately $6 million at the December 31, 2023 exchange rate). There is no maturity date under this facility until written notice is given. The facility bears interest at the Bolsa do Basil reference rate on outstanding balances. There is no borrowings outstanding under this facility at December 31, 2023.
Insurance premium financing
In August 2022, the Company entered into a $21 million insurance premium financing agreement with a third-party financing company. The balance was repaid in monthly installments over 10 months at a 5% fixed annual interest rate. In August 2023, the Company entered into a $27 million insurance premium financing agreement with a third-party financing company. The financing balance required a 33% down payment and will be repaid in monthly installments over 9 months at a 8% fixed annual interest rate. As of December 31, 2023 and 2022, the financing balance of these arrangements was $11 million and $10 million, respectively, and is recorded in "Short-term debt" in the Consolidated Balance Sheet.
Debt Covenants
At December 31, 2023, we are in compliance with all financial covenants in our debt facilities.
Interest and Debt Expense, Net
Interest and debt expense, net in the Consolidated Statements of Operations consisted of the following: | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
Interest on debt | $ | 157 | | | $ | 132 | | | $ | 148 | |
Amortization of deferred debt issuance costs and discounts on debt | 9 | | | 8 | | | 11 | |
Capitalized interest | (17) | | | (17) | | | (7) | |
Interest on capital leases and letters of credit and commitments | 9 | | | 2 | | | 5 | |
Total interest and debt expense, net | $ | 158 | | | $ | 125 | | | $ | 157 | |
In connection with obtaining debt, we incurred debt issuance costs, which are being amortized through the respective maturity dates on a straight-line basis for all of our debt facilities. At December 31, 2023 and December 31, 2022, we had deferred debt issuance costs of $1 million and $2 million, respectively, related to the Cash Flow Revolver, which is recorded in “Other long-term assets” in the Consolidated Balance Sheets. At December 31, 2023 and December 31, 2022, we had debt discounts of $10 million and $8 million, respectively, and debt issuance costs of $30 million and $33 million, respectively, primarily related to our term loans and senior notes, which were recorded as a direct reduction of the carrying value of the long-term debt in the Consolidated Balance Sheets.
14. Derivative Financial Instruments
Derivatives recorded on the Consolidated Balance Sheet:
The following table is a summary of the fair value of derivatives outstanding at December 31, 2023 and 2022:
| | | | | | | | | | | | | | | | | | | | | | | |
| Fair Value |
| December 31, 2023 | | December 31, 2022 |
| Assets(a) | | Accrued Liabilities | | Assets(a) | | Accrued Liabilities |
Derivatives Designated as Cash Flow Hedges |
| | | | | | | |
Interest Rate Swaps | $ | 18 | | | $ | — | | | $ | 30 | | | $ | — | |
Natural Gas Hedges | $ | — | | | $ | 1 | | | $ | 1 | | | $ | 2 | |
Total Hedges | $ | 18 | | | $ | 1 | | | $ | 31 | | | $ | 2 | |
Derivatives Not Designated as Cash Flow Hedges |
Currency Contracts | $ | 1 | | | $ | 1 | | | $ | 1 | | | $ | — | |
Total Derivatives | $ | 19 | | | $ | 2 | | | $ | 32 | | | $ | 2 | |
(a) At December 31, 2023 and 2022, current assets of $19 million and $32 million, respectively, are recorded in prepaid and other current assets on the Consolidated Balance Sheet.
Derivatives' Impact on the Consolidated Statements of Operations
The following table summarizes the impact of the Company's derivatives on the Consolidated Statements of Operations:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Amount of Pre-Tax Gain (Loss) Recognized in Earnings |
| Revenue | | Cost of Goods Sold | | Other Income (Expense), net | | Revenue | | Cost of Goods Sold | | Other Income (Expense), net | | Revenue | | Cost of Goods Sold | | Other Income (Expense), net |
| Year Ended December 31, 2023 | | Year Ended December 31, 2022 | | Year Ended December 31, 2021 |
Derivatives Not Designated as Hedging Instruments | | | | | | |
Currency Contracts | $ | — | | | $ | — | | | $ | 3 | | | $ | — | | | $ | — | | | $ | 1 | | | $ | — | | | $ | — | | | $ | 1 | |
Derivatives Designated as Hedging Instruments | | | | | | |
Currency Contracts | $ | — | | | $ | (4) | | | $ | — | | | $ | 4 | | | $ | 13 | | | $ | — | | | $ | (3) | | | $ | 35 | | | $ | — | |
Natural Gas | $ | — | | | $ | (5) | | | $ | — | | | $ | — | | | $ | 5 | | | $ | — | | | $ | — | | | $ | 3 | | | $ | — | |
Total Derivatives | $ | — | | | $ | (9) | | | $ | 3 | | | $ | 4 | | | $ | 18 | | | $ | 1 | | | $ | (3) | | | $ | 38 | | | $ | 1 | |
Interest Rate Risk
During the second quarter of 2019, we entered into interest-rate swap agreements with an aggregate notional value of $750 million representing a portion of our Term Loan Facility, which effectively converted the variable rate to a fixed rate for that portion of the loan. The agreements were to expire in September 2024.
On March 27, 2023, the Company entered into amendments to two of our existing interest rate swap agreements with the counterparty banks. As a result of these amendments, the Company terminated two of our existing interest rate swap contracts which were indexed to LIBOR with an aggregate notional value of $500 million which had maturity dates of September 2024. At the time of these amendments, the Company determined that the interest payments hedged are still probable to occur, therefore, the gains accumulated of $11 million on the interest rate swaps prior to the amendments are being amortized into interest expense through September 22, 2024, the original maturity of the interest rate swap agreements.
We simultaneously entered into two SOFR-indexed forward starting interest rate swaps with the same counterparty banks with no change to the aggregate notional value. The forward starting swaps became effective in June 2023 and will mature in March 2028 which is aligned with the maturity date of the Term Loan Facility. Indexing forward starting swaps to SOFR also ensured that the reference rates in our hedge instruments are now aligned with the interest rate terms of the Term Loan Facility which also changed from LIBOR to SOFR in June 2023 in anticipation of Reference Rate Reform and pursuant to the loan agreement. We elected to apply the hedge accounting expedients in ASC Topic 848, Reference Rate Reform on Financial Reporting related to the following: 1) the assertion that the future forecasted transaction is still probable of occurring despite reference rate changes and 2) the assumption that the index of the future hedged transactions will match the index of the corresponding hedge instruments for the assessment of effectiveness.
Additionally, on March 27, 2023, the Company entered into a new interest rate swap with a $200 million notional value which matures in March 2028 and effectively converts the variable rate to a fixed rate for that portion of the 2022 Term Loan Facility.
On May 17, 2023, the Company entered into an agreement with the counterparty bank to amend the remaining $250 million notional of the three original interest rate swap contracts of $750 million aggregate notional value. As a result of this amendment, the Company changed the rate indexed in the contract from LIBOR to SOFR, effective June 30, 2023 in anticipation of the Reference Rate Reform and to align the index rate in this contract to that in the Term Loan Facility, as described above. This amendment did not change the notional value and the expiration date of this contract, which is set to expire in September 2024. We completed a hedge effectiveness test as a result of this amendment and determined that this hedge instrument continues to be highly effective, enabling us to continue to apply hedge accounting over the remaining term of this hedge relationship.
As of December 31, 2023, the Company maintains a total of $950 million of interest rate swaps with the objective in using the interest-rate swap agreements to add stability to interest expense and to manage the Company's exposure to interest rate movements. These interest rate swaps have been designated as cash flow hedges and involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount.
Fair value gains or losses on these cash flow hedges are recorded in accumulated other comprehensive loss and are subsequently reclassified into interest expense in the same periods during which the hedged transactions affect earnings. For the year ended December 31, 2023, 2022 and 2021, the amounts recorded in interest expense related to the interest-rate swap agreements were $26 million, $4 million and $16 million, respectively. At December 31, 2023 and December 31, 2022, the net unrealized gain was $18 million and the unrealized gain was $30 million, respectively, and was recorded in "Accumulated other comprehensive loss" on the Consolidated Balance Sheet.
Foreign Currency Risk
From time to time, we enter into foreign currency contracts used to hedge forecasted third party non-functional currency sales for our South African subsidiaries and forecasted non-functional currency cost of goods sold for our Australian subsidiaries. These foreign currency contracts are designated as cash flow hedges. Changes to the fair value of these foreign currency contracts are recorded as a component of other comprehensive (loss) income, if these contracts remain highly effective, and are recognized in net sales or costs of goods sold in the period in which the forecasted transaction affects earnings or are recognized in other income (expense), net when the transactions are no longer probable of occurring.
As of December 31, 2023, we had no outstanding amounts to reduce the exposure of our Australian subsidiaries’ cost of sales to fluctuations in currency rates or to reduce the exposure of our South African subsidiaries' third party sales to fluctuations in currency rates. At December 31, 2022, there was an unrealized net loss of $4 million recorded in "Accumulated other comprehensive loss" on the Consolidated Balance Sheet, which was fully recognized in earnings during the year ended December 31, 2023.
From time to time, we enter into foreign currency contracts for the South African Rand, Australian Dollar, Euro, Pound Sterling and Saudi Riyal to reduce exposure of our subsidiaries’ balance sheet accounts not denominated in our subsidiaries’ functional currency to fluctuations in foreign currency exchange rates. Historically, we have used forward contracts to reduce the
exposure. For accounting purposes, these foreign currency contracts are not considered hedges. The change in fair value associated with these contracts is recorded in “Other income (expense), net” within the Consolidated Statements of Operations and partially offsets the change in value of third party and intercompany-related receivables not denominated in the functional currency of the subsidiary. At December 31, 2023, there was (i) 837 million South African Rand (or approximately $46 million at the December 31, 2023 exchange rate), (ii) 153 million Australian dollars (or approximately $105 million at the December 31, 2023 exchange rate), (iii) 45 million Pound Sterling (or approximately $57 million at the December 31, 2023 exchange rate, (iv) 45 million Euro (or approximately $50 million at the December 31, 2023 exchange rate) and (v) 67 million Saudi Riyal (or approximately $18 million at the December 31, 2023 exchange rate) of notional amount of outstanding foreign currency contracts.
15. Fair Value Measurement
For financial instruments that are subsequently measured at fair value, the fair value measurement is grouped into levels. See Note 2.
Our debt is recorded at historical amounts. The following table presents the fair value of our debt and derivative contracts at both December 31, 2023 and December 31, 2022:
| | | | | | | | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 |
| Asset | Liability | | Asset | Liability |
Term Loan Facility | $ | — | | $ | 903 | | | $ | — | | $ | 876 | |
2022 Term Loan Facility | — | | 394 | | | — | | 388 | |
2023 Term Loan Facility | — | | 351 | | | — | | — | |
Standard Bank Term Loan Facility | — | | 64 | | | — | | 77 | |
Senior Notes due 2029 | — | | 956 | | | — | | 893 | |
Australian Government Loan | — | | 1 | | | — | | 1 | |
MGT Loan | — | | 25 | | | — | | 30 | |
Interest rate swaps | 18 | | — | | | 30 | | — | |
Natural gas hedges | — | | 1 | | | 1 | | 2 | |
Foreign currency contracts | 1 | | 1 | | | 1 | | — | |
We determined the fair value of the Term Loan Facility, the 2022 Term Loan Facility, the 2023 Term Loan Facility, and the Senior Notes due 2029 using quoted market prices, which under the fair value hierarchy is a Level 1 input. We determined the fair value of the Standard Bank Term Loan Facility utilizing transactions in the listed markets for similar liabilities, which under the fair value hierarchy is a Level 2 input. The fair value of the Australian Government Loan and MGT Loan is based on the contracted amount which is a Level 2 input.
We determined the fair value of the foreign currency contracts, natural gas hedges, and the interest rate swaps using inputs other than quoted prices in active markets that are observable either directly or indirectly. The fair value hierarchy for the foreign currency contracts, natural gas hedges, and interest rate swaps is a Level 2 input.
The carrying value of cash and cash equivalents, restricted cash, accounts receivable and accounts payable approximate fair value due to the short-term nature of these items.
16. Leases
Lease expense for the year ended December 31, 2023, 2022 and 2021 was comprised of the following:
| | | | | | | | | | | | | | | | | | | | |
| | Year Ended December 31, |
| | 2023 | | 2022 | | 2021 |
Operating lease expense | | $ | 37 | | | $ | 39 | | | $ | 47 | |
| | | | | | |
Finance lease expense: | | | | | | |
Amortization of right-of-use assets | | 6 | | | 4 | | | $ | 1 | |
Interest on lease liabilities | | 5 | | | 4 | | | $ | 2 | |
| | | | | | |
Short term lease expense | | 36 | | | 35 | | | $ | 30 | |
Variable lease expense | | 5 | | | 14 | | | $ | 23 | |
Total lease expense | | $ | 89 | | | $ | 96 | | | $ | 103 | |
The table below summarizes lease expense for the year ended December 31, 2023, 2022 and 2021 recorded in the specific line items, which are subsequently recorded in our Consolidated Statements of Operations:
| | | | | | | | | | | | | | | | | | | | |
| | Year Ended December 31, |
| | 2023 | | 2022 | | 2021 |
Cost of goods sold | | $ | 87 | | | $ | 92 | | | $ | 98 | |
Selling, general and administrative expenses | | 2 | | | 4 | | | 5 | |
Total | | $ | 89 | | | $ | 96 | | | $ | 103 | |
The weighted-average remaining lease term in years and weighted-average discount rates at December 31, 2023 and 2022 were as follows:
| | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 |
Weighted-average remaining lease term: | | | | |
Operating leases | | 11.1 | | 11.6 |
Finance leases | | 8.0 | | 8.8 |
| | | | |
Weighted-average discount rate: | | | | |
Operating leases | | 12.1 | % | | 10.8 | % |
Finance leases | | 12.1 | % | | 12.2 | % |
The maturity analysis for operating leases and finance leases at December 31, 2023 were as follows:
| | | | | | | | | | | | | | |
| | Operating Leases | | Finance Leases |
2024 | | 36 | | | 10 | |
2025 | | 24 | | | 9 | |
2026 | | 20 | | | 8 | |
2027 | | 16 | | | 8 | |
2028 | | 15 | | | 7 | |
Thereafter | | 120 | | | 25 | |
Total lease payments | | 231 | | | 67 | |
Less: imputed interest | | (104) | | | (24) | |
Present value of lease payments | | $ | 127 | | | $ | 43 | |
Additional information relating to cash flows and ROU assets for the year ended December 31, 2023, 2022 and 2021 is as follows:
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
Cash paid for amounts included in the measurement of lease liabilities: | | | | | | |
Operating cash flows used for operating leases | | $ | 40 | | | $ | 39 | | | $ | 51 | |
Operating cash flows used for finance leases | | $ | 5 | | | $ | 4 | | | $ | 2 | |
Financing cash flows used for finance leases | | $ | 5 | | | $ | 3 | | | $ | 1 | |
Additional information relating to ROU assets for the year ended December 31, 2023 and 2022 is as follows:
| | | | | | | | | | | | | | |
| | Year Ended December 31, |
| | 2023 | | 2022 |
ROU assets obtained in exchange for lease obligations: | | | | |
Operating leases obtained in the normal course of business | | $ | 21 | | | $ | 83 | |
Finance leases obtained in the normal course of business | | $ | 3 | | | $ | 37 | |
17. Asset Retirement Obligations
Asset retirement obligations consist primarily of rehabilitation and restoration costs, landfill capping costs, decommissioning costs, and closure and post-closure costs. Activity related to asset retirement obligations was as follows: | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 |
Balance, January 1 | $ | 161 | | | $ | 149 | |
Additions | 11 | | | 3 | |
Accretion expense | 15 | | | 12 | |
Remeasurement/translation | 1 | | | (7) | |
Changes in estimates, including cost and timing of cash flows | 7 | | | 7 | |
Settlements/payments | (9) | | | (3) | |
Other acquisition and divestiture related | — | | | — | |
Balance, December 31 | $ | 186 | | | $ | 161 | |
| | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Asset retirement obligations were classified as follows: | | | |
Current portion included in “Accrued liabilities” | $ | 14 | | | $ | 8 | |
Noncurrent portion included in “Asset retirement obligations” | 172 | | | 153 | |
Asset retirement obligations | $ | 186 | | | $ | 161 | |
We used the following assumptions in determining asset retirement obligations at December 31, 2023: inflation rates between 1.5% - 5.5% per year; credit adjusted risk-free interest rates between 6.0% -22.0%; the life of mines from less than 1 to 23 years and the useful life of assets between 5-44 years.
Environmental Rehabilitation Scheme
In accordance with applicable regulations, we established an environmental rehabilitation scheme for the prospecting and mining operations in South Africa, which receives, holds, and invests funds for the rehabilitation or management of asset retirement obligations. At December 31, 2023 and 2022, the total value of the assets held in the environmental rehabilitation scheme were $15 million and $12 million, respectively, which were recorded in “Other long-term assets” in the Consolidated Balance Sheets.
18. Commitments and Contingencies
Purchase and Capital Commitments—At December 31, 2023, purchase commitments were $285 million for 2024, $173 million for 2025, $167 million for 2026, $163 million for 2027, $291 million for 2028, and $1,475 million thereafter.
Letters of Credit—At December 31, 2023, we had outstanding letters of credit and bank guarantees of $109 million, of which $70 million were letters of credit (inclusive of $50 million related to the sale of Hawkins Point as discussed below) and $39 million were bank guarantees. Amounts for performance bonds were not material.
Environmental Matters— It is our policy to record appropriate liabilities for environmental matters when remedial efforts are probable and the costs can be reasonably estimated. Such liabilities are based on our best estimate of the undiscounted future costs required to complete the remedial work. The recorded liabilities are adjusted periodically as remediation efforts progress or as additional technical, regulatory or legal information becomes available. Given the uncertainties regarding the status of laws, regulations, enforcement policies, the impact of other potentially responsible parties, technology and information related to individual sites, we do not believe it is possible to develop an estimate of the range of reasonably possible environmental loss in excess of our recorded liabilities. We expect to fund expenditures for these matters from operating cash flows. The timing of cash expenditures depends principally on the timing of remedial investigations and feasibility studies, regulatory approval of cleanup projects, remedial techniques to be utilized and agreements with other parties. Included in these environmental matters are the following:
Hawkins Point Plant. Residual waste mud, known as Batch Attack Mud, and a spent sulfuric waste stream were deposited in an onsite repository (the “Batch Attack Lagoon”) at a former TiO2 manufacturing site, Hawkins Point Plant in Baltimore, Maryland, operated by Cristal USA, Inc. from 1954 until 2011. We assumed responsibility for remediation of the Hawkins Point Plant when we acquired the TiO2 business of Cristal in April 2019. On December 21, 2022, we sold the Hawkins Point Plant to the Maryland Port Administration ("MPA"), a state agency controlled by the Maryland Department of Transportation. Pursuant to the terms of the transaction, MPA became the lead party in developing and implementing appropriate measures to address, treat, control, and mitigate the environmental conditions at the property under the regulatory oversight of the Maryland Department of the Environment ("MPE"). Under MPA ownership, the Hawkins Point Plant will be utilized for storage and beneficial reuse of dredged material from the Port of Baltimore. In exchange for transferring ownership of the site to MPA, Tronox has agreed to make scheduled, annual payments to MPA which together with scheduled, annual contributions from MPA will be used to remediate the property. The sale of the property to MPA did not have a material impact to the Consolidated Statements of Operations. As of December 31, 2023, we have a provision of $42 million included in "Environmental liabilities" in our Consolidated Balance Sheet for the Hawkins Point Plant consistent with the accounting policy described above.
Other Matters— We are subject to a number of other lawsuits, investigations and disputes (some of which involve substantial amounts claimed) arising out of the conduct of our business, including matters relating to commercial transactions, prior acquisitions and divestitures, including our acquisition of Cristal, employee benefit plans, intellectual property, and environmental, health and safety matters. We recognize a liability for any contingency that is probable of occurrence and reasonably estimable. We continually assess the likelihood of adverse judgments of outcomes in these matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts. Included in these other matters is the following:
UK Health and Safety Matter. In April 2023, we received a summons from the UK Health and Safety Executive (HSE) alleging non-compliance with UK health and safety legislation at the Stallingborough pigment plant resulting from an incident involving a contractor in August 2021. In June 2023, Tronox Pigment UK Limited, the entity which owns the Stallingborough plant, pled guilty to the allegation. The sentencing hearing to determine monetary penalties occurred in September 2023. At such hearing, the judge imposed a monetary penalty in the amount of £207,681, inclusive of costs. We do not believe this matter will have a material adverse effect on our business, financial condition and results of operations. In addition, in February 2024, we received a second summons from the HSE alleging non-compliance with UK health and safety legislation at the Stallingborough pigment plant resulting from a separate incident involving an employee in August 2022. Based upon our current understanding, we do not believe the enforcement action with regards to this second incident will have a material adverse effect on our business, financial condition and results of operations.
Venator Materials plc v. Tronox Limited. In May 2019, Venator Materials plc (“Venator”) filed an action in the Superior Court of the State of Delaware alleging among other things that we owed Venator a $75 million “Break Fee” pursuant to the terms of a preliminary agreement dated July 14, 2018 (the “Exclusivity Agreement”). The Exclusivity Agreement required, among other things, Tronox and Venator to use their respective best efforts to negotiate a definitive agreement to sell the entirety of the National Titanium Dioxide Company Limited’s (“Cristal’s”) North American operations to Venator if a divestiture of all or a substantial part of these operations were required to secure the approval of the Federal Trade Commission for us to complete our acquisition of Cristal’s TiO2 business. In June 2019, we denied Venator's claims and counterclaimed against Venator seeking to recover $400 million in damages from Venator that we suffered as a result of Venator’s breaches of the Exclusivity Agreement. Specifically, we alleged, among other things, that Venator’s failure to use best efforts constituted a material breach of the Exclusivity Agreement and directly resulted in and caused us to sell Cristal’s North American operations to an alternative buyer for $701 million, $400 million less than the price Venator had agreed to in the Exclusivity Agreement. On April 6, 2022, the Judge presiding over the case in the Superior Court of the State of Delaware delivered a directed verdict in favor of Venator without allowing the jury to deliberate. The Company determined not to appeal the Judge's verdict, and as such, on April 18, 2022, the Company and Venator entered into a settlement agreement whereby the Company paid $85 million, inclusive of interest, on April 25, 2022. As a result, we recorded the charge within "Venator settlement" on the Consolidated Statement of Operations for the year ended December 31, 2022.
Western Australia Stamp Duty Matter. In May 2018, we lodged a pre-transaction determination request for a stamp duty exemption with the Western Australia Office of State Revenue (the “WA OSR”) in connection with our re-domicile transaction (the “Re-Domicile Transaction”). The WA OSR subsequently granted our request for an exemption in June 2018 on a preliminary basis. Immediately following the consummation of the Re-Domicile Transaction, we filed a confirmation request for the stamp duty exemption with the WA OSR. Following this confirmation request, we exchanged numerous communications with the WA OSR addressing questions raised and stating our position. In July 2021, the WA OSR informed us that they have reviewed their technical position on the applicability of the stamp duty exemption and have determined that such an exemption is disallowed. On April 8, 2022, the Company lodged an appeal of the WA OSR's decision with the Western Australia State Administrative Tribunal. On March 3, 2023, the WA OSR officially granted us the stamp duty exemption in connection with the Re-Domicile Transaction, and as such, the Tribunal proceeding was withdrawn.
19. Accumulated Other Comprehensive Loss Attributable to Tronox Holdings plc and Other Equity Items
The tables below present changes in accumulated other comprehensive loss by component for 2023, 2022 and 2021. | | | | | | | | | | | | | | | | | | | | | | | |
| Cumulative Translation Adjustment | | Pension Liability Adjustment | | Unrealized Gains (losses) on Derivatives | | Total |
Balance, January 1, 2021 | $ | (491) | | | $ | (120) | | | $ | 1 | | | $ | (610) | |
Other comprehensive income (loss) | (103) | | | 16 | | | 21 | | | (66) | |
Acquisition of noncontrolling interest | (34) | | | — | | | — | | | (34) | |
Amounts reclassified from accumulated other comprehensive loss | — | | | 4 | | | (32) | | | (28) | |
Balance, December 31, 2021 | (628) | | | (100) | | | (10) | | | (738) | |
Other comprehensive (loss) income | (82) | | | 5 | | | 53 | | | (24) | |
| | | | | | | |
Amounts reclassified from accumulated other comprehensive loss | — | | | 17 | | | (23) | | | (6) | |
Balance, December 31, 2022 | $ | (710) | | | $ | (78) | | | $ | 20 | | | $ | (768) | |
Other comprehensive (loss) income | (19) | | | (14) | | | (15) | | | (48) | |
Amounts reclassified from accumulated other comprehensive loss | — | | | — | | | 2 | | | 2 | |
Balance, December 31, 2023 | $ | (729) | | | $ | (92) | | | $ | 7 | | | $ | (814) | |
Repurchase of Common Stock
On November 9, 2021, the Company's Board of Directors authorized the repurchase of up to $300 million of the Company's stock through February 2024. During the year ended December 31, 2023, we made no repurchases of the Company's stock. In connection with the expiration in February 2024 of the Company's existing share repurchase program, on February 21, 2024, the Company's Board of Directors authorized the repurchase of up to $300 million of the Company's stock through February 21, 2027.
20. Share-based Compensation
Share-based compensation expense consisted of the following: | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
Total share-based compensation expense from restricted share units | $ | 21 | | | $ | 26 | | | $ | 31 | |
The stock compensation expense for the year ended December 31, 2023 is inclusive of a $4 million reduction of expense due to the 2021 performance grants. The stock compensation expense for the year ended December 31, 2021 is inclusive of a $3 million true up of expense due to the 2020 and 2021 performance grants as well as the acceleration of $2 million of stock compensation expense associated with the retirement agreement entered into with the former CEO on March 18, 2021.
Tronox Holdings plc Amended and Restated Management Equity Incentive Plan
On March 27, 2019, in connection with the Re-domicile Transaction, Tronox Holdings plc assumed the management equity incentive plan previously adopted by Tronox Limited, which plan was renamed the Tronox Holdings plc Amended and Restated Management Equity Incentive Plan. The amendments to the plan were made to provide, among other things, for the appropriate substitution of Tronox Holdings in place of Tronox Limited and to ensure the compliance with the laws of England and Wales law in place of Australian law. The MEIP permits the grant of awards that are comprised of incentive options, nonqualified options, share appreciation rights, restricted shares, restricted share units, performance awards, and other share-based awards, cash payments, and other forms as the compensation committee of the Board of Directors (the “Board”) in its discretion deems appropriate, including any combination of the above. The maximum number of shares which were initially subjected to awards (inclusive of incentive options) was 20,781,225 ordinary shares and was increased by 8,000,000 on the affirmative vote of our shareholders on June 24, 2020.
Restricted Share Units (“RSUs”)
On an annual basis, the Company grants RSUs which have time and/or performance conditions. Both the time-based awards and the performance-based awards are classified as equity awards.
2023 Grants- The Company granted both time-based and performance-based awards to certain members of management. A total of 872,660 of time-based awards were granted to management which will vest ratably over a three-year period ending March 5, 2026. A total of 90,088 of time-based awards were granted to non-employee members of the Board which will vest in May 2024. A total of 872,660 of performance-based awards were granted, of which 436,330 of the awards vest based on a relative Total Shareholder Return ("TSR") calculation and 436,330 of the awards vest based on certain performance metrics of the Company. The non-TSR performance-based awards vest on March 5, 2026 based on the actual 2025 annual return on invested capital (ROIC). Similar to the Company's historical TSR awards granted in prior years, the TSR awards vest based on the Company's three-year TSR versus the peer group performance levels. Given these terms, the TSR metric is considered a market condition for which we used a Monte Carlo simulation to determine the weighted average grant date fair value of $22.42.
Similar TSR awards were granted during 2022 and 2021 with a grant date fair values of $34.41 and $29.07 which was calculated utilizing a Monte Carlo simulation. The following weighted-average assumptions were utilized to value the grants in 2023, 2022 and 2021:
| | | | | | | | | | | | | | | | | |
| 2023 | | 2022 | | 2021 |
Dividend yield | N/A | | 3.22 | % | | 1.56 | % |
Expected historical volatility | 67.1 | % | | 68.0 | % | | 71.1 | % |
Risk free interest rate | 4.47 | % | | 3.06 | % | | 0.17 | % |
Expected life (in years) | 3 | | 3 | | 3 |
The following table presents a summary of activity for RSUs for 2023: | | | | | | | | | | | |
| Number of Shares | | Weighted Average Grant Date Fair Value |
Outstanding, January 1, 2023 | 3,790,404 | | | $ | 17.01 | |
Granted | 1,958,242 | | | 16.33 | |
Vested | (2,326,611) | | | 11.72 | |
Forfeited | (103,691) | | | 19.92 | |
Outstanding, December 31, 2023 | 3,318,344 | | | $ | 20.22 | |
Expected to vest, December 31, 2023 | 2,430,837 | | | $ | 19.36 | |
The 2020 performance-based RSUs vested above target in 2023 and resulted in 122,834 additional RSU shares being granted and vested immediately. At December 31, 2023, there was $29 million of unrecognized compensation expense related to nonvested RSUs, adjusted for estimated forfeitures, which is expected to be recognized over a weighted-average period of 1.8 years. The weighted-average grant-date fair value of RSUs granted during 2023, 2022 and 2021 was $16.33 per unit, $19.47 per unit, and $20.91 per unit, respectively. The total fair value of RSUs that vested during 2023, 2022 and 2021 was $27 million, $44 million and $41 million, respectively.
Options
We did not issue any options during 2023, 2022 and 2021 and all our options outstanding are fully vested at December 31, 2023. The following table presents a summary of option activity for 2023: | | | | | | | | | | | | | | | | | | | | | | | |
| Number of Options | | Weighted Average Exercise Price | | Weighted Average Contractual Life (years) | | Intrinsic Value |
Outstanding, January 1, 2023 | 515,092 | | | $ | 20.55 | | | 0.62 | | $ | — | |
Exercised | — | | | — | | | | | |
Forfeited | 3,842 | | | 20.30 | | | | | |
Expired | (301,291) | | | 19.41 | | | | | |
Outstanding and Exercisable, December 31, 2023 | 217,643 | | | $ | 22.13 | | | 0.13 | | $ | — | |
The aggregate intrinsic values in the table represent the total pre-tax intrinsic value (the difference between our share price at the indicated dates and the options’ exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at the end of the year. The amount will
change based on the fair market value of our stock. During 2022 and 2021, there were 13,881 and 424,832 options exercised, respectively, with a total intrinsic value of less than $1 million and $2 million, respectively. We issue new shares upon the exercise of options. During 2022 and 2021, we received less than $1 million and $8 million, respectively, in cash for the exercise of stock options. There were no options exercised during 2023 and consequently, there was no related intrinsic value. At December 31, 2023, 2022 and 2021, there was no unrecognized compensation expense related to options.
21. Pension and Other Postretirement Healthcare Benefits
The following provides information regarding our U.S. and foreign plans:
U.S. Plans
Pension and Postretirement Healthcare Plans— Tronox has one main U.S. defined benefit plan: the U.S. Qualified Plan. The U.S. Qualified Plan is a funded noncontributory qualified benefit plan which is in accordance with the Employee Retirement Income Security Act of 1974 (“ERISA”) and the Internal Revenue Code. We made contributions into funds managed by a third party, and those funds are held exclusively for the benefit of the plan participants. Benefits under the U.S. Qualified Plan were generally calculated based on years of service and final average pay. The U.S. Qualified Plan was frozen and closed to new participants on June 1, 2009. In October 2022, the Company entered into an irrevocable arrangement with an insurance provider to settle certain lower dollar valued accounts within its frozen U.S Qualified Plan to reduce PBGC premiums. As a result of this arrangement, the Company recorded a non-cash pension settlement charge of approximately $20 million during the fourth quarter of 2022. We also maintain one postretirement healthcare plan - the U.S. retiree welfare plan.
International Plans
Pension Plans — Tronox has international defined benefit commitments primarily in the United Kingdom ("U.K. DB Scheme") and Saudi Arabia. The U.K. DB Scheme is a funded qualified defined benefit plan in the United Kingdom, which is frozen with no additional benefits accruing to the participants. Benefits under the U.K. DB Scheme are generally calculated based on years of credit service and final compensation when benefits ceased to accrue as defined under the plan provisions. We also maintain a Saudi Arabia Cristal End of Service Benefit plan which provides end of service benefits to qualifying participants. End of service benefits are based on years of service and the reasons for which a participant's services to the Company are terminated.
Multiemployer Pension Plan - In prior periods, we maintained a defined benefit plan in the Netherlands (the “Netherlands Plan”) to provide defined pension benefits to qualifying employees of Tronox Pigments (Holland) B.V. and its related companies. During 2014, the Netherlands Plan was replaced with a multiemployer plan, the Netherlands Contribution Plan (the "CDC Plan") effective January 1, 2015. Under the CDC Plan, employees earn benefits based on their pensionable salaries each year determined using a career average benefit formula. The collective bargaining agreement between us and the participants require us to contribute 20.4% of the participants’ pensionable salaries into a pooled fund administered by the industry-wide PGB. The pensionable salary is the annual income of employees subject to a cap, which is adjusted each year to reflect the current requirements of the Netherlands’ Wages and Salaries Tax Act of 1964. Our obligation under this plan is limited to the fixed percentage contribution we make each year. The employees are entitled to any returns generated from the investment activities of the fund.
The following table outlines the details of our participation in the CDC Plan for the year ended December 31, 2023. The CDC disclosures provided herein are based on the fund’s 2022 annual report, which is the most recently available public information. Based on the total plan assets and accumulated benefit obligation information in the plan’s annual report, the zone status was green as of December 31, 2022. A green zone status indicates that the plan was at least 80 percent funded. The “FIP/RP Status Pending/Implemented” column indicates whether a financial improvement plan (FIP) or a rehabilitation plan (RP) is either pending or has been implemented. As of December 31, 2023, we are not aware of any financial improvement or rehabilitation plan being implemented or pending. The last column lists the expiration date of the collective-bargaining agreement to which the plan is subject. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | Pension Protection Act Zone Status | | | | Tronox Contributions | | | | |
Pension Fund | | EIN/Pension Plan Number | | 2023 | | 2022 | | FIP/RP Pending/ Implemented | | 2023 | | 2022 | | Surcharge Imposed | | Expiration date of Collective- Bargaining Agreement |
PGB | | NA | | N/A | | Green | | No | | $ | 5 | | | $ | 5 | | | No | | 12/31/2024 |
On the basis of the information available in the CDC Plan 2022 annual report, our contribution does not constitute more than 5 percent of the total contribution to the plan by all participants. During 2023, the fund did not impose any surcharge on us.
Postretirement Healthcare Plans — We also maintain postretirement healthcare plans in South Africa (the "South African Plan") and Brazil (the "Brazil Medical Plan"). The South African Plan provides medical and dental benefits to certain South African employees, retired employees and their registered dependents. The South African Plan provides benefits as follows: (i) members employed before March 1, 1994 receive 100% post-retirement and death-in-service benefits; (ii) members employed on or after March 1, 1994 but before January 1, 2002 receive 2% per year of completed service subject to a maximum of 50% post-retirement and death-in-service benefits; and, (iii) members employed on or after January 1, 2002 receive no post-retirement and death-in-service benefits. The Brazil Medical Plan provides post-employment medical benefits to employees who contributed to the medical plan while employed. Retirees receiving a benefit under the plan are required to pay a contribution that varies based on the coverage level elected.
Pension and Postretirement Benefit Costs / Obligations
Benefit Obligations and Funded Status — The following provides a reconciliation of beginning and ending benefit obligations, beginning and ending plan assets, funded status, and balance sheet classification of our U.S. and international pension plans and other post-retirement benefit plans ("OPEB") as of and for the years ended December 31, 2023 and 2022. The benefit obligations and plan assets associated with our principal benefit plans are measured on December 31.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pensions | | Other Post Retirement Benefit Plans |
| December 31 | | December 31 |
| 2023 | | 2022 | | 2023 | | 2022 |
| US | International | | US | International | | US | International | | US | International |
Change in benefit obligations: | | | | | | | | | | | |
Benefit obligation, beginning of year | $ | 199 | | $ | 154 | | | $ | 369 | | $ | 234 | | | $ | 1 | | $ | 17 | | | $ | 2 | | $ | 16 | |
Service cost | — | | 3 | | | — | | 4 | | | — | | 1 | | | — | | 1 | |
Interest cost | 11 | | 7 | | | 10 | | 4 | | | — | | 2 | | | — | | 2 | |
Net actuarial (gains) losses | 13 | | 5 | | | (77) | | (61) | | | — | | 6 | | | (1) | | (1) | |
Curtailments | — | | — | | | — | | — | | | — | | (1) | | | — | | — | |
Settlements | — | | — | | | (81) | | — | | | — | | — | | | — | | — | |
Plan amendments(1) | — | | — | | | — | | — | | | — | | — | | | — | | — | |
Foreign currency rate changes | — | | 5 | | | — | | (17) | | | — | | — | | | — | | — | |
Benefits paid | (24) | | (11) | | | (22) | | (10) | | | — | | (1) | | | — | | (1) | |
Benefit obligation, end of year (2) | 199 | | 163 | | | 199 | | 154 | | | 1 | | 24 | | | 1 | | 17 | |
Change in plan assets: | | | | | | | | | | | |
Fair value of plan assets, beginning of year | 180 | | 106 | | | 337 | | 183 | | | — | | — | | | — | | — | |
Actual return on plan assets | 20 | | 3 | | | (63) | | (53) | | | — | | — | | | — | | — | |
Employer contributions | — | | 5 | | | — | | 4 | | | — | | 1 | | | — | | 1 | |
Benefits paid | (24) | | (11) | | | (22) | | (10) | | | — | | (1) | | | — | | (1) | |
Foreign currency rate changes | — | | 6 | | | — | | (18) | | | — | | — | | | — | | — | |
Settlements | — | | — | | | (72) | | — | | | — | | — | | | — | | — | |
Fair value of plan assets, end of year | 176 | | 109 | | | 180 | | 106 | | | — | | — | | | — | | — | |
Net underfunded status of plans | $ | (23) | | $ | (54) | | | $ | (19) | | $ | (48) | | | $ | (1) | | $ | (24) | | | $ | (1) | | $ | (17) | |
Classification of amounts recognized in the Consolidated Balance Sheets: |
Other long-term assets | $ | — | | $ | 10 | | | $ | — | | $ | 10 | | | $ | — | | $ | — | | | $ | — | | $ | — | |
Accrued liabilities | — | | (7) | | | — | | (6) | | | — | | (1) | | | — | | — | |
Pension and postretirement healthcare benefits | (23) | | (57) | | | (19) | | (52) | | | (1) | | (23) | | | (1) | | (17) | |
Total liabilities | (23) | | (64) | | | (19) | | (58) | | | (1) | | (24) | | | (1) | | (17) | |
Accumulated other comprehensive (income) loss | 64 | | 11 | | | 55 | | 4 | | | — | | 8 | | | — | | 2 | |
Total | $ | 41 | | $ | (43) | | | $ | 36 | | $ | (44) | | | $ | (1) | | $ | (16) | | | $ | (1) | | $ | (15) | |
________________
(1) Relates to a plan amendment entered into during 2021 related to the Brazil Medical Plan.
(2) Since the benefits under the U.S Qualified Plan and the U.K. DB Scheme are frozen, the projected benefit obligation and accumulated benefit obligation are the same.
Contributions
At a minimum, Tronox contributes to its pension plans to comply with local regulatory requirements (e.g., ERISA in the United States). Discretionary contributions in excess of the local minimum requirements are made based on many factors, including long-term projections of the plans' funded status, the economic environment, potential risk of overfunding, pension insurance costs and alternative uses of the cash. Changes to these factors can impact the timing of discretionary contributions from year to year. Pension contributions for its US and international plans were approximately $6 million in 2023 and are currently expected to be approximately $8 million in 2024.
The following table provides information for pension plans where the accumulated benefit obligation exceeds the fair value of the plan assets:
| | | | | | | | | | | |
| Pensions |
| 2023 |
| US | | International |
Projected benefit obligation (PBO) | $ | 198 | | | $ | 63 | |
Accumulated benefit obligation (ABO) | $ | 198 | | | $ | 42 | |
Fair value of plan assets | $ | 175 | | | $ | — | |
Expected Benefit Payments — The following table shows the expected cash benefit payments for the next five years and in the aggregate for the years 2029 through 2033:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 2024 | | 2025 | | 2026 | | 2027 | | 2028 | | 2029-2032 |
Pensions - US | $ | 19 | | | $ | 19 | | | $ | 19 | | | $ | 18 | | | $ | 17 | | | $ | 76 | |
Pensions - International | $ | 13 | | | $ | 9 | | | $ | 10 | | | $ | 10 | | | $ | 11 | | | $ | 51 | |
Other Post Retirement Benefit Plans - US | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | 1 | |
Other Post Retirement Benefit Plans - International | $ | — | | | $ | 1 | | | $ | 1 | | | $ | 1 | | | $ | 1 | | | $ | 10 | |
Retirement and Postretirement Healthcare Expense — The table below presents the components of net periodic cost associated with the U.S. and foreign plans recognized in the Consolidated Statements of Operations for 2023, 2022, and 2021:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pensions | | Other Postretirement Benefit Plans |
| Year Ended December 31, | | Year Ended December 31, |
| 2023 | | 2022 | | 2021 | | 2023 | | 2022 | | 2021 |
Net periodic cost: | | | | | | | | | | | |
Service cost | $ | 3 | | | $ | 5 | | | $ | 4 | | | $ | 1 | | | $ | — | | | $ | 1 | |
Interest cost(1) | 18 | | | 14 | | | 14 | | | 2 | | | 2 | | | 2 | |
Expected return on plan assets(1) | (20) | | | (24) | | | (26) | | | — | | | — | | | — | |
Net amortization of actuarial loss(1) | — | | | 4 | | | 5 | | | — | | | — | | | 1 | |
Settlement losses (gains)(1) | — | | | 20 | | | — | | | — | | | — | | | — | |
Curtailment (gains)(1) | — | | | — | | | — | | | — | | | — | | | — | |
Total net periodic cost | $ | 1 | | | $ | 19 | | | $ | (3) | | | $ | 3 | | | $ | 2 | | | $ | 4 | |
________________
(1) Recorded in Other income (expense), net in the Consolidated Statements of Operations.
Assumptions —
The following weighted average assumptions were used to determine net periodic cost: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pension | | |
| 2023 | | 2022 | | 2021 |
| US | | International | | US | | International | | US | | International |
Discount rate | 5.70 | % | | 4.70 | % | | 2.97 | % | | 1.91 | % | | 2.60 | % | | 1.47 | % |
Expected return on plan assets | 7.50 | % | | 4.00 | % | | 6.80 | % | | 2.50 | % | | 6.70 | % | | 2.50 | % |
| | | | | | | | | | | |
| OPEB | | |
| 2023 | 2022 | | 2021 |
| US | | International | | US | | International | | US | | International |
Discount rate | 5.62 | % | | 10.59 | % | | 2.83 | % | | 10.29 | % | | 2.59 | % | | 10.19 | % |
Expected return on plan assets | N/A | | N/A | | N/A | | N/A | | N/A | | N/A |
The following weighted average assumptions were used in estimating the actuarial present value of benefit obligations: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pensions | | |
| 2023 | | 2022 | | | | 2021 |
| US | | International | | US | | International | | US | | International |
Discount rate | 5.42 | % | | 4.45 | % | | 5.70 | % | | 4.70 | % | | 2.97 | % | | 1.87 | % |
Rate of compensation increase | N/A | | 4.76 | % | | N/A | | 4.72 | % | | N/A | | 4.68 | % |
| | | | | | | | | | | |
| OPEB | | |
| 2023 | | 2022 | | | | 2021 |
| US | | International | | US | | International | | US | | International |
Discount rate | 5.95 | % | | 10.50 | % | | 5.62 | % | | 11.10 | % | | 2.83 | % | | 10.33 | % |
Rate of compensation increase | N/A | | N/A | | N/A | | N/A | | N/A | | N/A |
For the U.S. Qualified Plan, at both December 31, 2023 and December 31, 2022, the mortality assumption was determined using the Society of Actuaries' the generational projection scale (i.e. MP-2021) and base table (i.e. Pri-2012).
Expected Return on Plan Assets — In forming the assumption of the U.S. and international long-term rate of return on plan assets, we considered the expected earnings on funds already invested, earnings on contributions expected to be received in the current year, and earnings on reinvested returns. The long-term rate of return estimation methodology for the Company's pension plans is based on a capital asset pricing model using historical data and a forecasted earnings model. An expected return on plan assets analysis is performed which incorporates the current portfolio allocation, historical asset-class returns, and an assessment of expected future performance using asset-class risk factors.
Discount Rate — The 2023 and 2022 rates were selected based on the results of a cash flow matching analysis, which projected the expected cash flows of the plans using a yield curves model developed from a universe of Aa-graded U.S. currency corporate bonds (obtained from Bloomberg) with BVAL scores of 6 or greater.
Plan Assets — The investments of the U.S. and International pension plans are managed to meet the future expected benefit liabilities of the plan over the long term by investing in diversified portfolios consistent with prudent diversification and historical and expected capital market returns. Tronox's U.S. and international pension plans’ weighted-average asset allocations at December 31, 2023 and 2022, and the target asset allocation ranges, by major asset category, are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
| US | | International | | US | | International |
| Actual | | Target | | Actual | | Target | | Actual | | Target | | Actual | | Target |
| | | | | | | | | | | | | | | |
Equity securities | 49 | % | | 50 | % | | — | % | | — | % | | 49 | % | | 46 | % | | — | % | | — | % |
Debt securities | 47 | | | 47 | | | 38 | | | 38 | | | 46 | | | 46 | | | 37 | | | 37 | |
Real estate | 1 | | | 1 | | | — | | | — | | | 1 | | | — | | | — | | | — | |
Other | 3 | | | 2 | | | 62 | | | 62 | | | 4 | | | 8 | | | 63 | | | 63 | |
Total | 100 | % | | 100 | % | | 100 | % | | 100 | % | | 100 | % | | 100 | % | | 100 | % | | 100 | % |
The fair values of pension investments as of December 31, 2023 are summarized below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | |
| | | Fair Value Measurement at December 31, 2023 Using: |
| | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | | | Significant Other Observable Inputs (Level 2) | | | Significant Unobservable Inputs (Level 3) | | | | Total |
Asset category: | | | | | | | | | | | | | | |
Equities securities: | | | | | | | | | | | | | | |
Global equity securities | | | $ | 48 | | | | (1) | $ | — | | | | $ | — | | | | | $ | 48 | |
Global commingled equity funds | | | 38 | | | | (2) | — | | | | — | | | | | 38 | |
Debt securities: | | | | | | | | | | | | | | |
US government bonds | | | 48 | | | | (3) | — | | | | — | | | | | 48 | |
Foreign government bonds | | | 22 | | | | (3) | — | | | | — | | | | | 22 | |
US corporate bonds | | | — | | | | | 34 | | | (4) | — | | | | | 34 | |
Foreign corporate bonds | | | — | | | | | 21 | | | (4) | — | | | | | 21 | |
Real Estate: | | | | | | | | | | | | | | |
Property/ real estate fund | | | — | | | | | 1 | | | (5) | — | | | | | 1 | |
Other: | | | | | | | | | | | | | | |
Insurance contracts | | | — | | | | | — | | | | 63 | | | (7) | | 63 | |
Cash & cash equivalents | | | 10 | | | | (6) | — | | | | — | | | | | 10 | |
Total at fair value | | | $ | 166 | | | | | $ | 56 | | | | $ | 63 | | | | | $ | 285 | |
________________
(1)For global equity securities, this category is comprised of shares of common stock in both U.S. and international companies from a diverse set of industries and size. Common stock is valuated at the closing market price reported on a U.S. or international exchange where the security is actively traded. Equity securities are classified within level 1 of the fair value hierarchy.
(2)Global commingled equity funds are comprised of managed funds that invest in common stock of both U.S. and international companies shares from a diverse set of industries and size. Common stock are valued at the closing market price reported on a U.S. or international exchange where the security is actively traded. These funds are classified within level 1 of the fair value hierarchy.
(3)For US and foreign government bonds, this category includes U.S. treasuries, U.S. federal agency obligations and international government debt. The fair value of these investments are based on observable quoted prices on active exchanges, which are level 1 inputs.
(4)For US corporate bonds and foreign corporate bonds, this category is comprised of corporate bonds of U.S. and foreign companies from a diverse set of industries and size. The fair values for the U.S. and foreign corporate bonds are determined using quoted prices of similar securities in active markets and observable data or broker or dealer quotations. The fair values for these investments are classified as level 2 within the valuation hierarchy.
(5)For property / real estate funds, this category includes real estate properties, partnership equities and investments in operating companies. The fair value of the assets is determined using discounted cash flows by estimating an income stream for the property plus a reversion into a present value at a risk adjusted rate. Yield rates and growth assumptions utilized are derived from market transactions as well as other financial and industry data. The fair value of these investments are classified as level 2 in the valuation hierarchy.
(6)Cash and cash equivalents include cash and short-interest bearing investments with maturities of three months or less. Investments are valued at cost plus accrued interest. Cash and cash equivalents are classified within level 1 of the valuation hierarchy.
(7)For insurance contracts, the fair value is estimated as the cost of purchasing equivalent annuities on terms consistent with those currently available in the market. The contracts are with highly rated insurance companies and are classified within level 3 of the valuation hierarchy. The following table summarizes changes in fair value of the pension plan assets classified as level 3 for the year ended December 31, 2023:
| | | | | | | | |
| | Insurance Contracts |
Balance, December 31, 2022 | | $ | 63 | |
Actual return on plan assets | | 2 | |
Purchases, sales, settlements | | (5) | |
Transfers in/out of Level 3 | | — | |
Foreign currency translation | | 3 | |
Balance, December 31, 2023 | | $ | 63 | |
The fair values of pension investments as of December 31, 2022 are summarized below:
| | | | | | | | | | | | | | | | | | | | | | | |
| Fair Value Measurement at December 31, 2022, Using: |
| Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Total |
Asset category: | | | | | | | |
Equities securities: | | | | | | | |
Global equity securities | $ | 53 | | (1) | $ | — | | | $ | — | | | $ | 53 | |
Global commingled equity funds | 35 | | (2) | — | | | — | | | 35 | |
Debt securities: | | | | | | | |
US government bonds | 48 | | (3) | — | | | — | | | 48 | |
Foreign government bonds | 19 | | (3) | — | | | — | | | 19 | |
US corporate bonds | — | | | 34 | | (4) | — | | | 34 | |
Foreign corporate bonds | — | | | 22 | | (4) | — | | | 22 | |
Real Estate: | | | | | | | |
Property/ real estate fund | — | | | 1 | | (5) | — | | | 1 | |
Other: | | | | | | | |
Insurance contracts | — | | | — | | | 63 | | (7) | 63 | |
Cash & cash equivalents | 11 | | (6) | — | | | — | | | 11 | |
Total at fair value | $ | 166 | | | $ | 57 | | | $ | 63 | | | $ | 286 | |
________________
(1)For global equity securities, this category is comprised of shares of common stock in both U.S. and international companies from a diverse set of industries and size. Common stock is valuated at the closing market price reported on a U.S. or international exchange where the security is actively traded. Equity securities are classified within level 1 of the fair value hierarchy.
(2)Global commingled equity funds are comprised of managed funds that invest in common stock of both U.S. and international companies shares from a diverse set of industries and size. Common stock are valued at the closing market price reported on a U.S. or international exchange where the security is actively traded. These funds are classified within level 1 of the fair value hierarchy.
(3)For US and foreign government bonds, this category includes U.S. treasuries, U.S. federal agency obligations and international government debt. The fair value of these investments are based on observable quoted prices on active exchanges, which are level 1 inputs.
(4)For US corporate bonds and foreign corporate bonds, this category is comprised of corporate bonds of U.S. and foreign companies from a diverse set of industries and size. The fair values for the U.S. and foreign corporate bonds are determined using quoted prices of similar securities in active markets and observable data or broker or dealer quotations. The fair values for these investments are classified as level 2 within the valuation hierarchy.
(5)For property / real estate funds, this category includes real estate properties, partnership equities and investments in operating companies. The fair value of the assets is determined using discounted cash flows by estimating an income stream for the property plus a reversion into a present value at a risk adjusted
rate. Yield rates and growth assumptions utilized are derived from market transactions as well as other financial and industry data. The fair value of these investments are classified as level 2 in the valuation hierarchy.
(6)Cash and cash equivalents include cash and short-interest bearing investments with maturities of three months or less. Investments are valued at cost plus accrued interest. Cash and cash equivalents are classified within level 1 of the valuation hierarchy.
(7)For insurance contracts, the fair value is estimated as the cost of purchasing equivalent annuities on terms consistent with those currently available in the market. The contracts are with highly rated insurance companies and are classified within level 3 of the valuation hierarchy. The following table summarizes changes in fair value of the pension plan assets classified as level 3 for the year ended December 31, 2022:
| | | | | | | | |
| | Insurance Contracts |
Balance, December 31, 2021 | | $ | 98 | |
Actual return on plan assets | | (20) | |
Purchases, sales, settlements | | (5) | |
Transfers in/out of Level 3 | | — | |
Foreign currency translation | | (10) | |
Balance, December 31, 2022 | | $ | 63 | |
Defined Contribution Plans
U.S. Savings Investment Plan
In 2006, we established the U.S. Savings Investment Plan (the “SIP”), a qualified defined contribution plan under Section 401(k) of the Internal Revenue Code. Under the SIP, our regular full-time and part-time employees contribute a portion of their earnings, and we match these contributions up to a predefined threshold. Our matching contribution is 100% of the first 6% of employee contributions. Effective January 1, 2013, we established a profit sharing contribution at 6% of employees’ pay (“discretionary contribution”). A discretionary contribution of 6% was made for 2023, 2022 and 2021. Our matching contribution to the SIP vests immediately; however, our discretionary contribution is subject to vesting conditions that must be satisfied over a three-year vesting period. Contributions under the SIP, including our match, are invested in accordance with the investment options elected by plan participants. Compensation expenses associated with our matching contribution to the SIP was $4 million, $5 million and $5 million during 2023, 2022 and 2021, respectively, which was included in “Selling, general and administrative expenses” in the Consolidated Statements of Operations. Compensation expense associated with our discretionary contribution was $5 million in 2023, $5 million in 2022 and $5 million in 2021, which was included in “Selling, general and administrative expenses” in the Consolidated Statements of Operations.
U.S. Benefit Restoration Plan
In 2006, we established the U.S. Benefit Restoration Plan (the “BRP”), a nonqualified defined contribution plan, for employees whose eligible compensation is expected to exceed the IRS compensation limits for qualified plans. Under the BRP, participants can contribute up to 20% of their annual compensation and incentive. Our matching contribution under the BRP is the same as the SIP. Our matching contribution under this plan vests immediately to plan participants. Contributions under the BRP, including our match, are invested in accordance with the investment options elected by plan participants. Compensation expense associated with our matching contribution to the BRP was $1 million, $1 million and $1 million during 2023, 2022 and 2021, respectively, which was included in “Selling, general and administrative expenses” in the Consolidated Statements of Operations.
South Africa Defined Contribution Plans
Tronox Mineral Sands Proprietary Limited, a wholly owned subsidiary of the Company, participates in several defined contribution plans which are registered in the Republic of South Africa and are governed by the South African Pension Funds Act of 1956. These plans provide retirement and other benefits to all permanent employees, and where applicable, retired employees and their dependents. The Company contributes a range of 10% to 15% (depending on the plan) of the employees' predefined pre-tax pensionable earnings. Compensation expense associated with these plans was $8 million, $7 million, and $5 million during 2023, 2022 and 2021, respectively, which was included in both "Costs of goods sold" and "Selling, general and administrative expenses" in the Consolidated Statements of Operations.
22. Related Party Transactions
Tasnee / Cristal
At December 31, 2023 Cristal International Holdings B.V. (formerly known as Cristal Inorganic Chemical Netherlands Cooperatief W.A.), a subsidiary of Tasnee, continues to own 37,580,000 shares of Tronox, or a 24% ownership interest.
On May 9, 2018, we entered into an Option Agreement with AMIC which is owned equally by Tasnee and Cristal. Under the terms of the Option Agreement, AMIC granted us an option (the “Option”) to acquire 90% of a special purpose vehicle (the “SPV”), to which AMIC’s ownership in a titanium slag smelter facility (the “Slagger”) in The Jazan City for Primary and Downstream Industries in KSA will be contributed together with $322 million of AMIC indebtedness (the "AMIC Debt"). The AMIC Debt would remain outstanding debt of the SPV upon exercise of the Option. The Option may be exercised if the Slagger achieves certain production criteria related to sustained quality and tonnage of slag produced (the “Option Criteria”). Likewise, AMIC may require us to acquire the Slagger on the same terms if the Option Criteria are satisfied. Furthermore, pursuant to the Option Agreement we lent AMIC $125 million for capital expenditures and operational expenses intended to facilitate the start-up of the Slagger (the “Tronox Loans”).
On May 13, 2020, we amended the Option Agreement (the "First Amendment") with AMIC to address circumstances in which the Option Criteria cannot be satisfied. Pursuant to the First Amendment, Tronox has the right to acquire the SPV in exchange for (i) our forgiveness of the Tronox Loans principal and accrued interest thereon, and (ii) the SPV's assumption of $36 million of indebtedness plus accrued interest thereon lent by AMIC to the SPV. Under the First Amendment, the SPV would not assume any of the AMIC Debt.
On May 10, 2023, AMIC and Tronox further amended the Option Agreement (the “Second Amendment”). In the Second Amendment the parties acknowledged that the Option expired on May 10, 2023 without being exercised but agreed to continue negotiating until September 30, 2023 (the "Renegotiation Period") as to whether, and under what circumstances, Tronox may acquire the Slagger. Subsequent to September 30, 2023, the parties continued to negotiate as to whether, and under what circumstances, Tronox may acquire the Slagger and on February 21, 2024 they again amended the Option Agreement (the “Third Amendment”), which extended the Renegotiation Period until the earlier of the repayment of the Tronox Loans or December 31, 2024, subject to certain early termination rights. The Third Amendment also provided that from the date the parties entered into the Second Amendment and through December 31, 2023, all chloride slag produced by the Slagger was to be delivered to Tronox as repayment in-kind of the Tronox Loans at a price based on a widely published index for feedstock less a nominal discount (the “Slag Price”). Thereafter and until the end of the Renegotiation Period, 65% of all chloride slag produced by the Slagger will be delivered to Tronox as repayment in-kind of the Tronox Loans based on the Slag Price and Tronox will purchase via cash settlements the remaining 35% at the Slag Price. Full repayment of the Tronox Loans is required by January 2025 in either cash or in-kind through chloride slag deliveries. During July 2023, we also entered into an agreement with AMIC to act as their sales agent with regard to sales of slag fines to customers outside of the Kingdom of Saudi Arabia for an agreed upon commission fee to be paid.
The following table shows the outstanding balance of the Tronox Loans, which is recorded in "Other long-term assets" on the Consolidated Balance Sheet:
| | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Principal balance | 80 | | 125 |
Accrued interest income balance | 12 | | 13 |
Total outstanding balance | 92 | | 138 |
The following table shows the interest income earned on the Tronox Loans, which is recorded in "Interest income" on our Consolidated Statement of Operations:
| | | | | | | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 | | 2021 |
Interest income | 5 | | 4 | | 3 |
The following table shows the amount of feedstock purchased from the Slagger, which is subsequently recorded in "Cost of goods sold" on our Consolidated Statement of Operations:
| | | | | | | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 | | 2021 |
Settled as in-kind repayment of Tronox Loans | 44 | | | — | | | — | |
Settled in cash | 80 | | | 60 | | | — | |
Total chloride slag purchases | 124 | | | 60 | | | — | |
The following table shows the amounts due to AMIC at period-end regarding the purchase feedstock purchased from the Slagger, which are recorded in "Accrued liabilities" on our Consolidated Balance Sheet:
| | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Amount due to AMIC for slag purchases | — | | | 14 | |
In addition, on March 15, 2018 Tronox and AMIC entered into a Technical Services Agreement (the "Original Technical Services Agreement"), which was subsequently amended on May 13, 2020, May 10, 2023 and February 21, 2024 (the "Restated Technical Services Agreement"). Through September 30, 2023 we provided technical advice and project management services, however AMIC and its consultants were still responsible for engineering and construction of the Slagger. As compensation for these services, Tronox received certain fees, including a management fee. In the Consolidated Statement of Operations and shown in the table below, the management fees per the Original Technical Services Agreement were recorded within "Other income, net" and other technical support fees, including fees per the Restated Technical Services Agreement, are recorded within "Selling, general and administrative" costs. From and after October 1, 2023, we no longer receive a management fee and the scope of services we provide is more limited, for which we receive cost reimbursement plus a nominal margin.
| | | | | | | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 | | 2021 |
Management fees | 6 | | 8 | | 8 |
Other technical support fees | 2 | | 2 | | — | |
Total fees received | 8 | | 10 | | 8 |
Outstanding balances for these fees receivable are shown below, which are recorded within “Prepaid and other assets” on the Consolidated Balance Sheet:
| | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Management fees and other technical support fees | 1 | | 2 |
On December 29, 2019, we entered into an agreement with Cristal to acquire certain assets co-located at our Yanbu facility which produce metal grade TiCl4 ("MGT"). Consideration for the acquisition was the assumption by Tronox of a $36 million note payable to Cristal (the "MGT Loan"). MGT is used at a titanium "sponge" plant facility, 65% of the ownership interests of which are held by Advanced Metal Industries Cluster and Toho Titanium Metal Co. Ltd ("ATTM"), a joint venture between AMIC and Toho Titanium Company Ltd. ATTM uses the TiCl4, which we supply by pipeline, for the production of titanium sponge, a precursor material used in the production of titanium metal.
On December 17, 2020 we completed the MGT transaction. Repayment of the $36 million note payable is based on a fixed U.S. dollar per metric ton quantity of MGT delivered by us to ATTM over time and therefore the ultimate maturity date is variable in nature. If ATTM fails to purchase MGT from us under certain contractually agreed upon conditions, then at our election we may terminate the MGT supply agreement with ATTM and will no longer owe any amount under the loan agreement with Cristal. We currently estimate the ultimate maturity to be between approximately four and five years, subject to actual future MGT production levels. The interest rate on the note payable is based on the SAIBOR plus a premium. As shown in the table below, the note payable is recorded within "Long-term debt, net" and "Long-term debt due within one year" on the Consolidated Balance Sheet.
| | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Note payable, due within 1 year | 7 | | 7 |
Note payable, due longer than 1 year from now | 18 | | 23 |
Total outstanding note payable | 25 | | 30 |
Amounts regarding interest expense and loan repayments for the MGT loan, which are recorded on the Consolidated Statement of Operations within “Interest expense” and “Net sales,” respectively, are shown below:
| | | | | | | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 | | 2021 |
Interest expense | 2 | | 1 | | 1 |
Loan Repayment via MGT delivered to ATTM | 6 | | 3 | | 4 |
As a result of these transactions we have entered into related to the MGT assets, Tronox purchases chlorine gas from ATTM for use in the production of MGT and such transactions are reflected as follows:
| | | | | | | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 | | 2021 |
Purchases of chlorine gas | 5 | | 4 | | 8 |
These purchases are subsequently recorded within “Cost of goods sold” on the Consolidated Statement of Operations. Amounts due at period end, which are presented below, are recorded within “Accrued liabilities” on the Consolidated Balance Sheet.
| | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Amount due related to purchases of chlorine gas | 1 | | 1 |
As Tronox delivers MGT product to ATTM, amounts are recorded within “Net sales” on the Consolidated Statement of Operations, as shown below:
| | | | | | | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 | | 2021 |
MGT sales made to ATTM as product is delivered | 47 | | 29 | | 31 |
Amounts related to MGT deliveries that are outstanding at period end are recorded in “Prepaid and other assets” on the Consolidated Balance Sheet, as shown below:
| | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Due from ATTM for MGT deliveries | 9 | | 6 |
23. Segment Information
We operate our business under one operating segment, Tronox, which is also our reportable segment. The Company's chief operating decision maker, who are its Co-CEOs, reviews financial information presented at the consolidated level for purposes of allocating resources and evaluating financial performance. Since we operate our business under one segment, there is no difference between our consolidated results and segment results.
We disaggregate revenue from contracts with customers by product type and geographic area as well as sales based on country of production. We believe this level of disaggregation appropriately depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors and reflects how our business is managed.
During 2023, 2022 and 2021 our ten largest third-party customers represented 39%, 30%, and 28%, respectively, of our consolidated net sales. During 2023, 2022, and 2021, no single customer accounted for 10 % of our consolidated net sales.
Net sales to external customers based on country of production, were as follows: | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
U.S. operations | $ | 686 | | | $ | 733 | | | $ | 716 | |
International operations: | | | | | |
United Kingdom | 267 | | | 331 | | | 396 | |
Australia | 659 | | | 822 | | | 873 | |
South Africa | 398 | | | 484 | | | 441 | |
Saudi Arabia | 318 | | | 419 | | | 420 | |
Other - international | 522 | | | 665 | | | 726 | |
Total net sales | $ | 2,850 | | | $ | 3,454 | | | $ | 3,572 | |
See Note 3 for further information on revenues.
There is no difference between the total consolidated assets and our segment assets. Property, plant and equipment, net, mineral leaseholds, net, and lease right of use assets, net by geographic region, were as follows: | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
U.S. operations | $ | 299 | | | $ | 308 | |
International operations: | | | |
United Kingdom | 103 | | | 93 | |
Saudi Arabia | 222 | | | 226 | |
South Africa | 701 | | | 705 | |
Australia | 1,048 | | | 1,093 | |
Other - international | 248 | | | 242 | |
Total | $ | 2,621 | | | $ | 2,667 | |